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Adverse tissue reactions to hip prostheses containing CoCr alloys have been widely reported, 
particularly for implants utilising a metal-on-metal bearing surface or, more recently, a modular 
taper junction and have been termed Adverse Response to Metal Debris (ARMD). Histological 
assessments of synovial tissues from patients at revision operation often demonstrate an 
extensive accumulation of macrophages and abundant tissue necrosis or fibrosis. The 
inflammatory response starts with the recruitment of immune cells and requires the egress of 
macrophages from the inflamed site for resolution of the reaction. Metal particles have 
previously been shown to affect cell migration but the effects of cobalt and chromium on 
macrophages’ motility remain largely unknown.  
In vitro and in vivo macrophage migration during exposure to cobalt and chromium ions and 
nanoparticles were examined in this thesis. Cobalt, but not chromium, was found to 
significantly reduced macrophage motility (>50%). This was found to involve an increase in 
both cell spreading and the formation of intracellular podosome-type adhesion structures, as 
well as enhanced cell adhesion to the extracellular matrix (ECM). The formation of podosomes 
was also associated with the production and activation of matrix metalloproteinase-9 (MMP9) 
and enhanced ECM degradation. These effects were driven by the down-regulation of RhoA 
signalling through the generation of reactive oxygen species (ROS).  
The effect of the Co2+ and Cr3+ metal ions on tissue remodelling and pseudotumour formation 
which can lead to pain, swelling, limited range of joint movement and extensive tissue lesions, 
was explored using a multiscale approach.  Both 2D and 3D in vitro culture systems were 
deplored to examine the effects of these ions on human fibroblast activation and 
mechanobiology. It was observed that Co2+ induced a fibrotic response characterised by 
cytoskeletal remodelling and enhanced collagen matrix contraction. This was associated with 
an increase in cell stiffness (~45%) and contractile forces (~80%) measured by atomic force 
microscopy and traction force microscopy, respectively. These effects were also triggered by 
the generation of ROS. Moreover, this fibrotic response was enhanced in the presence of 
macrophages, which increased the prevalence of α-SMA positive fibroblasts and collagen 
synthesis. These events were verified in vivo by examining the synovial fibroblasts and tissues 
from hips of patients with metal-on-metal hip implants and patients undergoing primary hip 
replacement. The findings revealed that fibroblasts isolated from patients undergoing MoM 
revision THA were more biomechanically active than the control group. Moreover, synovial 
tissues from patients undergoing MoM revision THA displayed evidence of extensive tissue 
remodelling and fibrosis.  
These findings revealed that cobalt leads to adverse tissue reactions via inducing macrophage 
retention, fibroblast-mediated matrix remodelling and modulating the interplay between 
macrophage and fibroblast. These distinctive effects can help us understand the pathogenesis 
of ARMD and the cellular response to cobalt-based alloys, which will inform biocompatibility 
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Chapter 1. Introduction 
Millions of people worldwide suffer from end-stage hip joint diseases that require treatment to 
restore their function and eliminate pain to provide an improved life of quality. One of the 
widely applied procedures is a total hip arthroplasty (THA). In 2016, 87,733 primary hip 
replacements were conducted in the UK alone with nearly 8,000 hip revision procedures 
performed largely due to the aseptic loosening, pain and adverse reaction to metal debris 
(ARMD) from CoCr alloys. These numbers are increasing every year according to the National 
Joint Registry (National Joint Registry for England, 2017). Although the use of metal-on-metal 
hip replacements has virtually ceased, implants containing CoCr alloys are still being widely 
utilised, including in dental and spinal prostheses and modular heads in metal-on-polyethylene 
couplings.  
There have been numerous studies to investigate the causes of ARMD (Matharu et al., 2016). 
A wide range of in vivo and in vitro studies have been conducted to elucidate the contributing 
factors and mechanisms underline the pathogenesis of ARMD. However, the factors involved 
in its progression have not been completely understood. In an attempt to link the cellular 
response to the deleterious effects related to CoCr products in vivo, the health endpoint of most 
in vitro studies are cytotoxicity and cell death. Although the metal content detected in vivo can 
vary greatly among different patients (Davda et al., 2011), it seems unlikely that investigations 
focused on acute toxicity will provide a solution to fully understanding CoCr debris related 
ARMD. It is reasonable to assume that cells in vivo will be exposed to highly varying levels of 
Co2+ and Cr3+ ions and particles, which in most cases, rather than directly inducing cell death 
or triggering acute inflammatory responses, have effects on the cellular behaviour or 
functionality that disrupt tissue homeostasis. Understanding the cell-type specific reactions will 





cobalt and chromium based alloys, and provide useful information for future implant design 























Chapter 2. Literature review 
2.1 The hip joint  
The hip approximates to a ball and socket joint and is connected between the longest bone in 
the body, the femur, and the pelvis at the distal to the trunk (Dowson and Wright, 1981). It is 
one of the largest and heavily loaded joint in the human body the conditions which both a 
natural and prosthetic hip operates in are complex and challenging.  
2.1.1 Anatomy  
The hip joint is a well-structured mechanism that transfers the upper body weight to the lower 
limb and enables motion. The hip joint can be divided into three main components, namely the 
femur, acetabulum and acetabular capsule that is formed by surrounding soft tissues.  
2.1.1.1 Femur  
The femur consists of a long cylindrical shaft (diaphysis), which joins the metaphyses. The 
proximal region of femur consists of the femoral neck, the greater and lesser trochanters and 
the femoral head. The approximately spherical femoral head is covered with articular cartilage 
to articulate with the pelvis at the acetabulum; the structure allows the accommodation of a 
wide range of motion, suitable for locomotion and other activities. In addition, an uncovered 
cartilage area occurs on the central area of the femoral head – the fovea capitis, where a small 
depression region allows the capsule ligament to be attached. The femoral neck connects the 
femoral shaft to the head as a superomedial projection, which extends inferolaterally from the 
head at an angle of approximately125o to the femoral long axis. The head is located anterior to 
the midline of the shaft of the femur thereby creating an approximately 5-15 o neck-shaft angle.   
The femoral neck and its orientation allows space between the head and shaft, which results in 
facilitating a wide range of movement of the hip joint. Importantly, the muscles and ligaments 





is formed by cortical bone with the epiphysis and metaphysis consisting of primarily cancellous 
bone that covered with a thin layer of cortical bone.  
  
Figure 2.1 Illustration showing the basic anatomy of the femur.  
2.1.1.2 Acetabulum 
There are three components forming the acetabulum namely the pubis, the ilium and the 
ischium; these are fused to create the acetabulum within the pelvis that thereby creates an 
articulation surface for the femoral head. The stability of the hip joint is provided by the 
acetabulum accommodating the surface of the femoral head, with soft tissues providing 
restraints. The surface of the acetabulum includes the articulating lunate surface as well as the 
non-articular part, the acetabular fossa. The acetabulum is broadest in the superior region of 








2.1.1.3 Synovial membrane and the joint capsule  
The synovial membrane is a layer of connective tissue that lines the joint capsule. The Synovial 
membrane of the hip joint originates from the margins of the articulation region and attaches 
to the femur neck. It also extends and covers the non-articular area of the acetabulum thus 
providing a tubular covering for the ligament of the femoral head. In addition, a thick fibrous 
membrane, external to the synovial membrane, encloses the joint and seals the joint capsule 
from its surrounding. The joint is further stabilised by three ligaments - the ilio-femoral, ischo-
femoral and pubo-femoral ligaments. These ligaments retain the femur lightly in the capsule, 
preventing extension beyond the straight position, limiting abduction and movements of 
rotational movements whilst permitting flexion up to approximately 130o. The synovial fluid 
is generated by the synovial membrane; this fluid provides both lubrication and nutrition to the 
bearing surface. The iliopectineal bursa acts as a fluid reservoir to contain synovial fluid that 
egresses from the joint space when the pressure within the joint capsule is excessive. The flow 
is reversed when the pressure of the joint capsule decreases below that of the bursa. The 
pressure in normal and healthy joints is maintained approximately constant utilising this 
mechanism during physical activity. In some problematic joints, it is known that the pressure 
can rise up to 69 kPa in some cases while it is only just above the atmospheric pressure in 







Figure 2.2 Image showing the cross-section view of the hip joint capsule. (Source: 
www.stanfordhealth.org) 
2.1.2 Kinematics and biomechanics of the hip  
The morphology of the hip joint and the organisation of ligaments around the capsule provides 
a structure that make the best use of muscle force for standing and joint movement. Motion of 
the hip joint may be described as extension, abduction, flexion, adduction, internal and external 
rotations with circumduction described as a combination of all the other motions. Walking 
transmits forces which are multiples of body weight through the hip joint, while jogging, 
running and activities in many sports generating forces which are significantly greater. Many 
in vivo measurements have been carried out using prostheses and endoprostheses instrumented 
with transducers (strain-gauges). Rydell (1966) was the first to attempt measuring direct hip 
joint forces using an instrumented hip prosthesis, which yielded force magnitudes of 2.3 to 2.9 
times body weight for single leg stance and 1.6 to 3.3 times body weight for level walking 
(Cowin, 2001). More extensive studies have been carried out, summarised in Table 2.1, which 
have shown that although patients in the early postoperative period can execute planned 





stumbling or periods of instability during single leg stance can generate resultant forces in 
excess of eight times of body weight.  
Table 2.1. Hip contact forces measured in vivo in patients with instrumented implants 
(Callaghan et al., 2007).  
 
2.2 Total hip arthroplasty  
Total hip arthroplasty (THA) is a highly successful and widespread surgical treatment in 
restoring function to the synovial joints of the body. There are nearly 895,292 primary total 
joint replacements performed in United Kingdom according to the National Joint Registry 14th 
Annual Report (2017). From the perspective of healthcare cost savings associated with 
implants with extended service life, there is a great interest in better understanding the factors 
that contribute to the success and longevity of total joint replacements.  
2.2.1 A brief history of total hip arthroplasty 
THA has completely revolutionised the way that a diseased hip is treated, and is considered to 
be one of the most successful surgical treatments of its generation. Surgeons had employed a 
variety of biocompatible materials ranging from muscles, chromatised pig bladder to glasses, 
ivory, magnesium and zinc to restore mechanical functionality of the joint. Glück made the 
first attempt in hip replacement by using ivory to replace femoral heads of patients whose hip 





surface for motion utilising a glass hollow hemisphere fitting over the femoral head. However, 
it failed to withstand the forces transmitted through the hip joint and shattered. Later, stainless 
steel was applied to create the first total hip replacement that was fitted to bone with bolts and 
screws. The orthopaedic surgeon Sir John Charnley is considered the father of the modern THA, 
who designed the low friction arthroplasty in the early 1960's, which is consider as the 
forerunner to the modern prostheses in use today.  This implant can be considered in three parts: 
a polyethylene acetabular cup, a metal femoral stem and acrylic bone cement (Charnley, 1961). 
It was called the low friction arthroplasty as he advocated the application of small femoral 
heads which could decrease wear due to a small articulating surface area. Despite its great 
success, not all THA provide the patient with satisfactory long-term results due to associated 
complications, with, in some cases, means a revision surgery is required to replace the 
problematic implant, which is typically a more demanding procedure with inferior results 
compared to the primary procedure.                                                                                                   
2.2.2 Conditions leading to total hip arthroplasty  
The need for a total hip replacement results from damage to the articular cartilage associated 
with disease, trauma, or normal “wear and tear”. Cartilage is not innervated and hence the 
lubrication mechanisms operating in healthy tissue can withstand repetitive loading of the joint 
without causing any pain. However, if the cartilage is damaged by disease, extended use or 
trauma, intense pain may occur as the innervated bones of the synovial joint come into direct 
contact. Osteoarthritis, Rheumatoid arthritis, and trauma are the three primary sources of 
damage in articular cartilage (AAOS, 2010). The primary disease of the hip is degenerative 
arthritis (osteoarthritis), and is usually described as the degeneration and progressive loss of 
normal structure and function of articular cartilage (Buckwalter and Mankin, 1998), which 
ultimately results in painful bone contact. Rheumatoid arthritis is a systemic disease in which 





number of synovial joints in the body. In addition, trauma is the result of physical injury that 
damages the cartilage or fractures the hip joint. 
2.2.3 Components of a total hip replacement 
The components of a modern total hip replacement include the femoral elements comprising 
the head, neck, and stem that fixate into the femur as well as the acetabular components 
encompassing the acetabular shell and liner, which are positioned in the acetabula region of the 
pelvis. Each of these components contributes to the functional requirements of the total hip 
replacement, including articulation and wear resistance of the acetabular liner and femoral head 
and fatigue resistance of the stem. Table 2.2 summarises the functional properties of 
components in THAs.   
 Table 2.2 Functional properties of the components in THAs   
Component Functional 
requirement  
Materials     Modern THA 
Acetabular shell Compressive strength 









Wear resistance UHMWPE 
CoCr alloys 
Zirconia 







or alumina  
Neck Flexural strength 







Femoral stem Fatigue resistance 
Corrosion resistance 
Compliance match to 














2.2.4 Metal bearing surfaces  
2.2.4.1 Bearing surface combinations and the phasing out of MoM bearing 
Over the past decades, diverse bearing combinations have been introduced, abandoned and 
reintroduced, reflecting the constant studies, improved understanding and improved material 
options since THA was first introduced. The bearing articulation has included the development 
of several combinations including metal-on-polyethylene (MOP), ceramic-on-polyethylene 
(COP), metal-on-metal (MOM) and ceramic-on-ceramic (COC). A comparison of different 
bearing surface combinations is illustrated in Table 2.3. 
Table 2.3 Comparison of different bearing surface combinations (Barsoum, 2010). 
                
 
Metal bearings were introduced in the early stages in the development of THAs. An advantage 
of utilising MOM bearing surfaces is that it could drastically reduce the risk of postoperative 
instability and demonstrated favourable wear rates as a result of the possibility to use of larger 
femoral heads compared with traditional MOP bearing surfaces. In addition, MOM bearings 





polyethylene. However, the particles generated by the MOM bearings could be 13–500 times 
smaller than that of MOP bearings (Doorn et al., 1998). These particles were found to lead to 
both a local soft tissue reactions and a systemic increase in serum Co2+ and Cr3+ levels (Davda 
et al., 2011). In 2010, Depuy issued a recall of its articular surface replacement (ASR) MOM 
arthroplasty system based on the devices’ high failure rate. The recall was based on data from 
the National Joint Registry of England and Wales that showed the five-year revision rate for 
arthroplasties involving the ASR XL Acetabular System and the ASR Hip Resurfacing System 
was 13% and 12% respectively (National Joint Registry for England, 2010). This was regarded 
as unacceptably high level as artificial hips are widely expected to function properly in situ for 
at least 10 to 15 years. The loosening, osteolysis and metal sensitivity that resulted from the 
generation of metal particle were thought to be the main reasons of the recall (de Steiger et al., 
2011). It was also revealed that large diameter metal-on-metal implants from other 
manufacturers showed high failure rates, especially in women (Cohen, 2012). In 2011, a two 
year follow-up study of 144 patients reported an incremental increase in metal levels with large 
head MOM hip prostheses from manufactures which included Zimmer, DePuy, and Smith and 
Nephew (Lavigne et al., 2011). Since the recall, the application of large-head MOM THA has 
sharply decreased from 20 % in 2005 to less than 1 % in 2012. Currently, there exists no role 
for large-head MOM THA in current clinical practice, although there are still many factors 
unknown about the MOM bearing.  
2.2.4.2 Characterisation of the wear particles generated from THA implants  
Electron microscopy and energy dispersive X-ray spectroscopy (EDS) have been applied to 
study the physicochemical characteristics of the wear particles in tissues, retrieved prostheses, 
or the isolated wear particles derived from MOM implants (Goode et al., 2012, Doorn et al., 
1998, Xia et al., 2011). Doorn et al. investigated the particles from revision MOM hip 





irregular boundaries and some of them displayed a spike-like shape. In addition, they were in 
general smaller than 50 nm (range 6-834 nm) (Madl et al., 2015a, Doorn et al., 1998). Campbell 
et al. isolated particles from the periprosthetic tissues of a patient with well-functioning MOM 
total hip prosthesis and showed wear particles to be of a comparable size range (18-472 nm). 
Similarly, the majority of them were oval-shaped (around 40%) or needle-shaped (around 40%) 
with the rest spherical (Campbell et al., 2003). Although the metal particulates from the tissue 
samples and retrieved implants were largely within the nanometer size range, it has also been 
shown that these particles may agglomerate and form larger or micron sized particles (Buscher 
et al., 2005, Morlock et al., 2008). Wear particles from periprosthetic tissues of patients with 
failed MOM prostheses are significantly smaller than those generated in MOP prostheses, when 
the CoCr wear particles, which were found to be spherical and elongated shaped particles, 
ranged from 0.07 to 6.3 μm in diameter (0.38 μm mean) compared to  0.57 to 12.2 μm in length 
(2.19 μm mean). Chemical analysis was also performed to investigate the chemical elements 
of wear debris of the periprosthetic tissue samples from MOM hip implant patients. Campbell 
et al. reported that nearly 50% of the particles in the tissues were CoCr alloy particles with the 
rest comprising a chromium oxide compound (Campbell et al., 2003). While Topolovec et al. 
only detected CoCr alloy particles and Ti particles from their analysis of the retrieved tissues 
of patients with MoM hip prostheses (Topolovec and Milosev, 2014). Although chromium has 
been found to be the main constituent, interestingly, some authors indicated that there were no 
particles which are solely comprised of purely Co (without Cr and Mo).  
Only a relatively small number of studies have characterised metal particles from synovial 
fluids. De Pasquale et al. analysed metal wear particulates from synovial fluid following the 
revision of MOM hips and reported that there were mostly micron-sized CoCr wear particles 
with only few particles with little or no cobalt content (De Pasquale et al., 2014). However it 





vivo wear particles due to the use of sodium hypochlorite, an alkaline solution for particles 
extraction that could significantly enhance the Cr dissolution from the particles and affect their 
physicochemical characteristics. Davda et al. used an acid oxidative digestion approache to 
isolate metal nanoparticles from 5 patients and found that the nanoparticles in the hip joint fluid 
contained primarily Cr (Davda et al., 2011). A study that included a much wider record of cases 
(32 unilateral MOM and 22 controls) reported that in the synovial fluid, the range of Co 
concentration was 11.50–64,550 mg/l (average 7,963.15 mg/l) for patients with MOM hip 
prostheses and 0.12–3.24 mg/l (average 0.93 mg/l) for the ‘‘healthy patients’’ undergoing 
primary hip surgery (Beraudi et al., 2013). Moreover, a retrospective study by Davda et al., 
2011 analysed chromium and cobalt concentrations in synovial fluid from a group of 92 
patients with failed MOM hip replacements using an acid oxidative digestion method. It was 
found that there was no significant difference for either Cr or Co ion levels between 
manufacturers in the synovial fluid and the range of Co and Cr concentration was 11 to 24,262 
mg/l (mean of 4,404 mg/l) and 13 to 185,731 mg/l (mean of 20,593 mg/l). In summary there is 
a wide variation of Co and Cr levels in synovial fluid and a standardised laboratory method is 
required to accurately determine metal content. 
Although the size of metal particles is smaller, it was suspected that the number of metal 
particles can be up to 100 times greater than that of polyethylene particles (Doorn et al., 1998). 
Consequently, the particles can lead to a much higher systemic release of Co2+ and Cr3+ ions as 
the total surface area of the metal particle exposed to the corrosive in vivo environment is 
greatly increased leading to a greater propensity for releasing metal ions. Abnormal serum Co2+ 
and Cr3+ levels have been widely reported in patients with MOM bearings from numerous 
studies. This has also been suggested to be associated with the use of large diameter heads 
(Smith et al. 2012). In 1998, Doorn et al. reported that levels of circulating Co2+ ions in serum 





observed during the bedding-in phase (median 1.1 µg/l after one year) (Doorn et al., 1998).  In 
a study by Jacobs et al., the circulating Co2+ and Cr3+ levels at 1 year after THA surgery were 
increased by 6 and 21 times respectively, compared to the preoperative measurements (Jacobs 
et al., 2003). Grübl reported the longest (10 years) follow-up of a series of cementless MOM 
THA and reported a mean serum concentration of cobalt of 0.75 μg/L (range, 0.3–50 μg/L) 
(Grubl et al., 2007).  A further study with a 10-year follow-up of MOM resurfacing patients by 
De Souza et al also showed that serum Co2+ and Cr3+ levels increased steeply over the initial 2 
years followed by a slow decline for both ions up to 5 years, while there appeared another 
increase of Co2+ and Cr3+ levels again in some patients between 5 and 10 years (deSouza et al., 
2010). A medical device alert was published to guide the surveillance of metal-on-metal hip 
arthroplasty by the United Kingdom Medicines and Healthcare products Regulatory Agency 
(MHRA) in April 2010. It was recommended that more frequent surveillance and further testing 
should be considered when whole blood levels of Co2+ and Cr3+ of a patient rise above 7 μg/l 
equivalent to parts per billion (ppb), which is the so called ‘‘action level’’ (Haddad et al., 2011). 
However, it was not encouraged to perform revision surgery based on blood metal ion levels 
alone due to the inadequate sensitivity of the threshold level of 7 µg/L to be used as a screening 
test for implant failure (Haddad et al., 2011). It also confirmed that blood metal ion levels can 
serve as a useful tool for diagnosis of failed metal-on-metal total hip arthroplasties.  
2.2.5 Modular taper junction and metal ions/particles release   
2.2.5.1 Introduction of modular taper junction  
With the aim of reproducing the natural biomechanics of the hip to maximise both function and 
longevity in total hip replacement, changes have been made in a range of design features, 
including the introduction of modular junctions. The dimensions, materials as well as surface 
finish of the taper can vary with the manufacturer. The design of a Morse taper refers back to 





widely adopted in dental implant, humeral components, intramedullary rods as well as THAs. 
These modular junctions include the modular femoral head–neck junction and neck-stem 
junction. In a modular neck-stem junction, there is a ‘double taper’ as the trunnion of the distal 
part of the neck engages with a bore created within the stem, as well as the proximal 
engagement of the neck with the head as illustrated in Figure 2.3.  
Figure 2.3 Illustration of the design of a modular head-neck taper junction.  
Modular necks offer the surgeon many intra-operative options, which are useful both in 
difficult primary and revision situations.  The design of modularity at the head–neck junction 
was developed by Weber in 1961, with the original design having a ‘little channel’ through the 
head, which allow fluid ingress to lubricate the bearing surface as well as the head–neck taper 
interface (Weber, 1970). Over the following 5 decades, along with improvement in materials, 








2.2.5.2 Advantages of modular taper junctions 
With the use of modular taper junction, the surgeon is able to optimise implant stability and 
range of motion because the implant’s geometry can be varied to optimize soft tissue tension. 
Furthermore, it is also useful in the prevention of impingement between the socket and neck, 
and bony and muscular impingement (Weber, 1970), as the stem version can be chosen 
intraoperatively according to patient’s individual anatomy.  
The most commonly used hip replacement device materials are the cobalt based alloys, or more 
specifically the cobalt–chromium–molybdenum (CoCrMo) system. The dominant implant 
alloy used is the ASTM F75 CoCrMo, details of its and other orthopedic alloy compositions 
are listed in Table 2.4. These alloys have shown to be a suitable choice of material for bearing 
surfaces due to their mechanical properties such as high strength (yield strength: 448–841 MPa; 
ultimate strength: 655–1277 MPa and excellent wear resistance including  hardnesses ranging 
from 300 HVN to 400 HVN (Patel, 2012).  However high levels of material loss have been 
reported to have occurred in some patients causing adverse tissue reactions because of the 
synergistic effect of wear and corrosion. Titanium and its alloys are also widely applied as hip 
implant material. But unlike high modulus CoCr stem, which is susceptible to fatigue fracture, 
titanium alloys exhibit a lower stiffness (Young’s modulus at 110 GPa vs. 210-253 GPa for 
CoCr Alloys) enable more physiological transmission of loads to the femur, reducing proximal 
stress shielding and thus prevent bone resorption in the proximal femur and failure of the 
cement mantel if cement is used (Yan, 2013). Modularity of the taper has made it possible to 
combine these materials in order to optimise fixation, resistance to fracture and improve the 
wear performance of bearing surfaces. 
 






A further advantage of introducing modularity occurs at the point of a revision surgery; these 
are simplified as the device’s modularity enables the head component to be removed while 
leaving a well-fixed femoral stem undisturbed thereby preserving proximal femoral bone stock. 
This is relevant when just the head is exchanged at the head–neck junction, such as changing 
the bearing surfaces for wear, adjusting the neck length, offset, head diameter and revision of 
the socket.  
2.2.5.3 Metal ions/particles release from the modular taper junction 
Although modular hip prostheses have many advantages in comparison to single component 
hip prostheses, the concerns about fretting and corrosion damage at the taper junction have 
become increasingly prominent. The idea that corrosion might occur at the head-neck taper of 
the femoral component was first described by Lucas (1981) in the early 1980s, and the concept 
that these taper junctions are susceptible to mechanically assisted crevice corrosion (MACC), 
a combination of fretting and crevice corrosion, was subsequently introduced (Gilbert et al., 
1994). Since that time, there have been numerous reports of corrosion at this taper interface, 
documented primarily in retrieval studies. The most significant problem regarding corrosion of 
the modular taper junction is that metal ions and particles can be generated from the taper 
interface due to corrosion (Brown et al., 1995, Garbuz et al., 2010, Mistry et al., 2016) which 
may stay bound to local tissues or circulate in the bloodstream and lymphatics  and therefore, 





loss based on measurement at the surface of the femoral head taper (Matthies et al., 2013, 
Langton et al., 2017b, Langton et al., 2017a, Hothi et al., 2017). Severe taper corrosion is often 
characterised by obvious black deposits present on the taper surface. The severity of corrosion 
at the taper junction of MOM THAs has been related to the whole blood metal ion levels of 
these patients (Hothi et al., 2016). It has been established that the highest median Co/Cr ratio 
are measured in patients with THA hips that showed severe corrosion of tapers junction, 
indicating that greater amount of Co ions were released into the blood from the taper corrosion 
byproducts. Vendittoli et al. measured the blood Co and Cr levels in the patients with large-
diameter head THAs (LDH-THA) to investigate the effects of modular junction on metal ions 
release. They found that the open femoral head design displayed higher Co concentrations (3.0 
μg/L) than the closed design (1.8 μg/L, p = 0.037). Moreover, the Co levels of LDH-THA were 
significantly higher than those with same bearing articulations from previously published data 
(Vendittoli et al., 2011), suggesting that a larger head size could be associated with increased 
taper corrosion and metal ions release. Intra-articular Co and Cr levels have also been measured 
in patients undergoing revision THA who had symptomatic taper corrosion. It was reported 
that in patients with mechanically assisted taper crevice corrosion, intra-articular Co level (940 
ppb) was significantly higher than serum Co (5.1 ppb) and intra-articular Cr (491 ppb) was also 
significantly higher than serum Cr (1.3 ppb) (McGrory et al., 2017). 
Metal corrosion products from the taper junction have also been widely reported in the 
periprosthetic tissues of patients with MOP implants. Gill et al., performed a study of a series 
of 35 patients who underwent THA with dual-modular short stem with MOP bearing surfaces 
(Gill et al., 2012). They reported that the mean blood levels of cobalt in patients with taper 
junctions were raised at 50.75 nmol/l (5-145) compared with 5.6 nmol/l (2-13) in control 
patients (who had an identical prosthesis and articulating surface without modular taper 





from corrosion at the femoral head-neck junction (Cooper et al., 2012). Increased serum metal 
levels, especially the distinctive elevation of Co2+ with respect Cr3+ levels are also found in 
these patients. 
2.3 Effects of CoCr wear particles and ions  
2.3.1 Local effects of CoCr wear particles and ions  
The deposition of CoCr wear particles and associated ions in peri-prosthetic tissues lead to a 
wide spectrum of necrotic and inflammatory reactions. These soft-tissue reactions have been 
variously interpreted and termed, including metallosis (Korovessis et al., 2006), aseptic 
lymphocytic vasculitis-associated lesions (ALVAL) (Willert et al., 2005), adverse reaction to 
metal debris (ARMD) (Matharu et al., 2016) and pseudotumours (Pandit et al., 2008). Although 
these soft tissue responses are not malignant or infectious, they can lead to catastrophic local 
tissue destruction (Pandit et al., 2008) and higher incidence of major complications after 
revision arthroplasty (Grammatopoulos et al., 2009). Metallosis is used to describe the 
macroscopic staining of the soft tissues by abnormal wear or corrosion products from the 
bearing surface or taper junction. Histologically, the soft tissue damages are often characterized 
by lymphocytes, macrophages, and necrosis with metallic and corrosion deposits (Willert et al., 
2005). Campbell et al., 2010 suggested a histologic scoring system which analyzed the 
presence of lymphocyte-predominant infiltration in the tissues, which is known as ALVAL 
(Campbell et al., 2010). It is believed to outcome of a type IV hypersensitivity response (Willert 
et al., 2005) that typically occurs in patients with low grade of metal wear (Langton et al., 2011). 
Pseudotumour is used to describe a mass, which could be solid or cystic or as a combination, 
which is usually diagnosed according to cross-sectional imaging or operative observations. 
Histological analysis of pseudotumours tends to show features described as ALVAL as well as 
tissue necrosis. ALTR was first proposed by Schmalzried et al., 2009 for describing all kinds 





products. Indeed there is no explicit consensus in the literature defining the boundaries of these 
terms. One study described the histopathology of adverse reactions to metal debris in 
association with failed metal on metal MOM hip arthroplasties of 123 patients (Natu et al., 
2012a). They found that 103 cases showed ALVAL, with 60 cases of the 103 patients also 
demonstrating a diffuse chronic lymphocytic synovitis, and 40 cases showing lymphoid 
aggregates with the remaining 17 cases demonstrating pure metallosis (Natu et al., 2012a). 
Campbell et al., 2010 examined the synovial tissues from MOM hips revised for suspected 
high wear related and suspected metal hypersensitivity cases, including 32 revised THAs. The 
ALVAL was scored by examination of synovial lining, inflammatory cell infiltration and tissue 
structure. High ALVAL scores were found to be associated with patients revised for pain and 
suspected metal sensitivity. They also observed considerable variability regarding the amount 
and distribution of metal particles and presence of inflammatory cells. Macrophages and 
lymphocytes were seen in all cases, while typical histologic features of high wear cases often 
displayed a diffuse, extensive infiltration of macrophages with a small aggregate of 
lymphocytes. Patients with a MOP hip prosthesis who underwent revision surgery for corrosion 
at the modular head-neck junction also showed large soft-tissue masses and surrounding tissue 
damage with dense infiltration of lymphocytes and macrophages (Jennings et al., 2016, Cooper 
et al., 2013), which is similar to the adverse local tissue reactions reported in patients with a 
MOM bearing.  
In general, it is believed that these soft tissue reactions may be attributed to two aetiologies: 
particle/ion-related cellular cytotoxicity and hypersensitivity (Campbell et al., 2010). Wear 
debris is mainly phagocytosed by macrophages and giant cells. Once the cells take in the 
particles, they corrode in the acidic intramedullary environment of the lysosomes and produce 
high intracellular levels of metal ions, particularly cobalt, which can cause cell death. When 





inflammation, osteolysis that leads to pain, limited range of motion and even failure of the 
implants.  
2.3.2 Cellular response to CoCr wear particles and ions  
The nature of the adverse tissue lesion has inevitably necessitated the study of the effects of 
metal wear particles on cells in vitro. Many studies on the effects of metal particles and 
associated ions on cells in vitro are of importance and clinical relevance because they take into 
account the size of the particles (in nano range) and the tendency of the CoCr particulates to 
dissociate metal ions into solution. The size of wear and corrosion products is critical as it 
affects the cellular uptake and even more, the bioactivity of the debris. Many cell lines have 
previously been used to investigate the effects of CoCr wear particles and ions including 
macrophages, lymphocytes, fibroblasts and osteoblasts. 
2.3.2.1 Macrophages response to CoCr wear particles and ions  
Macrophages are widely distributed immune cells that originate from monocytes, derived from 
the myeloid progenitor cells in the bone marrow and circulate in the blood stream. Upon 
infection, after toxic or mechanical injury or tissue damage, for example, at the early stage after 
implantation of a prosthesis, monocytes are rapidly recruited to the tissue and differentiate into 
tissue macrophages after a series of changes. Macrophages play an indispensable role in tissue 
homeostasis and defense by engulfing apoptotic cells, cell and tissue debris following tissue 
injury. Tissue macrophages and recruited monocytes also release numerous growth factors, 
such as platelet-derived (PDGF), insulin-like (IGF-1), and vascular endothelial (VEGF-α) 
growth factors to promote cell proliferation and angiogenesis, which help alleviate the local 






Figure 2.4 Proposed roles of macrophages at different stages after implantation of a prosthesis.  
Besides their critical regulatory activity at all stages of tissue injury and repair, they are also 
regarded as the primary contributors to potentially pathological inflammatory processes (Wynn 
et al., 2013). Innate immune implant particle and ion induced inflammation is caused 
predominantly by macrophages (Figure 2.4). Macrophages can effectively respond to 
implanted materials and able to engulf various biomaterial particles (Tondravi et al., 1997). 
Phagocytosis of CoCr wear particles by macrophages is a crucial step in the degradation of 
wear particulates and involves the activation of macrophages. Early in vitro studies of CoCr 
particles involved micron sized particles. Garrett et al., 1983 used the particles ranged from 30 
nm to 1.3μm, which were generated by milling in water or serum (Garrett et al., 1983). Mouse 
macrophages were exposed to these particles at a concentration of 30 μg/ml and noted that cell 
viability was reduced and the cell morphology was altered.  In addition, these metal particles 
were shown to inhibit the phagocytic activity of macrophages at 5μg/mL (the lowest tested 
dose). Interestingly, they also noted that the CoCr particles that were produced in serum 
remained dispersed in the medium solution, whereas the particles that were produced in 





phagocytosis activity of macrophage and internalisation of the particles. Moreover, by using 
CoCr particles at equal weight, many in vitro studies compared the cellular responses to 
particles of different size and demonstrated that CoCr nanoparticles are more toxic than their 
micron-sized counterparts (Papageorgiou et al., 2007, Raghunathan et al., 2013, Posada et al., 
2014). However, differences in toxicity are often absent when concentration is expressed as 
total surface area for nano and micron sized particles of the same element according to some 
other studies in nanotoxicology (Oberdorster et al., 2005, Duffin et al., 2007, Monteiller et al., 
2007, Stoeger et al., 2006). Germain et al., 2003 showed that nano-sized CoCr particles ranging 
from 5-200 nm decreased the viability of human macrophages at 0.5 μm3/cell while micro-
sized CoCr particles (> 10 µm) did not significantly reduce cell viability. In order to better 
understand the cellular response to CoCr wear debris, nanoparticles containing different 
species of Co and Cr were also examined in vitro. Both Lucarelli et al., and Kwon et al., 
reported that Co nanoparticles and soluble Co ions significantly reduced macrophage viability 
in a dose-dependent manner (Lucarelli et al., 2004, Kwon et al., 2009). On the other hand, Cr 
nanoparticles did not display a similar cytotoxic effect on macrophages as for Co nanoparticles. 
Lee et al. showed that CrPO4 particles did not induce a significant decrease in macrophage cell 
viability compared with unstimulated cells (Lee et al., 1997). VanOs et al., 2014 reported that 
Cr2O3 nanoparticles have minimal cytotoxic effects on macrophages and concluded that Cr 
nanoparticles particles are not the main cause of the inflammatory tissues reaction seen in 
patients with implants utilising CoCr alloys.  
Several mechanisms have been suggested to be associated with cobalt/chromium-induced cell 
damage. For example, Cr and Co have been shown to induce the intracellular reactive oxygen 
species formation that leads to oxidative damage (Raghunathan et al., 2013). It is well 
established that excessive production of ROS can induce a wide range of deleterious effects 





2011). It has been found that patients with MOM bearings who present the highest level of 
blood metal ions often showed the highest levels of protein carbonylation due to oxidative 
stress (Scharf et al., 2014), which helps to explain the tissue necrosis and formation of 
pseudotumors observed in patients with MOM implants. Cr and Co are thought to enhance 
ROS generation by promoting the conversion of hydrogen peroxide (H2O2) into reactive 
hydroxyl radicals (HO•) (Beyersmann and Hartwig, 2008) or directly binding to proteins to 
induce oxidation leading to the loss of biological function (Tkaczyk et al., 2010). Furthermore, 
some studies of the toxic effects of Co/Cr have revealed that it can hinder cellular Ca2+ entry, 
Ca2+ signaling and even occupy intracellular Ca2+ binding proteins. In addition, various 
receptors, ion channels and biomolecules can interact with Co2+ resulting in the dysfunction of 
cells.   
Once activated, macrophages release a wide array of cytokines, chemokines (Figure 2.5) to 
modulate the function properties and behaviors of other cell types in the inflammatory milieu. 
Kaufman et al., 2008 studied the response of primary human macrophages to CoCr particles 
(mean size of 0.48 µm) and quantify the secretion of 30 different cytokines and chemokines 
after 24 hours of culture. It was found that CoCr elicited significant increases in tumor necrosis 
factor-α (TNF-α, 17-fold, p < 0.05), Interleukin-6 (IL-6, 2.3-fold, p < 0.05), and IL-8 (2.3-fold, 
p < 0.05). Caicedo et al., 2010 reported that both soluble and particulate metal debris could 
induce monocyte/macrophage inflammatory responses. They found that IL-1β, which has been 
found to be elevated resulted from inflammasome activation, was upregulated in response to 
Co2+ and CoCrMo alloy particles (2 µm) but not observed for cells treated by nickel or Cr3+. 
The increased release of these cytokines, chemokine and growth-factor can initiate and 
exacerbate many biological activities of other types of cells. For example, a rise in the level of 
macrophage derived I-1 can induce neutrophil infiltration, angiogenesis and promote 





to play an essential role in the metal particles-induced bone-related diseases (Osta et al., 2014). 
Studies regarding the cytotoxicity and activation of macrophage due to CoCr ions and particles 
are summarised in Figure 2.5, Tables 2.5 and 2.6. 
Figure 2.5 Effects of Co2+ and CoNPs on oxidative stress mechanism and inflammation in 
macrophage signaling during ion and particle implant disease. 





Table 2.5 In vitro studies of the effect of Co2+ and Cr3+ on monocytes or macrophage-like cells 
Study Dose Cell Type(s) Key Findings and Results Health Endpoint (Assay) 
Catelas et al., 2001 Co2+: 0–10 ppm  
Cr3+: 0–500 ppm  
J774 mouse 
macrophages 
Both Co2+ and Cr3+ ions can induce dose-dependent macrophage 
mortality, and apoptosis with Co2+ being more toxic. The 
apoptosis occurs via a caspase-3 pathway. 
Cytotoxicity (MTT) 
Apoptosis  (DNA laddering; 
western blot) 
(Catelas et al., 
2003) 
Co2+: 0–10 ppm  
Cr3+: 0–500 ppm 
J774 mouse 
macrophages 
Both Co2+ and Cr3+ ions can induce the release of TNF-α and 
macrophage mortality in a dose- and time-dependent manner. 
More specifically, Co2+ and Cr3+ ions induced apoptosis after 
both 24 and 48 h incubation, although DNA analysis suggested 
the presence of necrosis at 48 h.  
Cytotoxicity (trypan blue 
exclusion; flow cytometry) 
Apoptosis  (DNA laddering; 
western blot) 
(Huk et al. 2004) Co2+: 2–10 ppm  
Cr3+: 50–500 ppm 
J774 mouse 
macrophages 
The mode of cell death due to Co2+ and Cr3+ was dependent on 
the ion concentration and the incubation time. At short 
incubation times (24 h), the non-inflammatory process of 
apoptosis was predominant. At longer incubation times (48 h), 
however, necrosis was predominant at higher ion 
concentrations.  
Cell death ELISA  
TEM 
(Luo et al. 2005) Co2+: 5–10 ppm  
Cr3+: 100–200 ppm 
U937 macrophages Tyrosine kinases regulate the activation of MMP-1, TIMP-1, 
and TNF-α by Co2+ and Cr3+ ions, which may contribute to 
prosthetic loosening. 
Inflammation  
(western blot, RT-PCR) 
 
(Catelas et al., 
2005) 
Co2+: 0–10 ppm  




   
Apoptosis was predominant after 24 h induced by both Co2+ and 
Cr3+ ions, but high concentrations of those induced mainly 
necrosis at 48 h, which indicates the potential for these ions of 
inducing tissue damage by necrosis if present in large 
concentrations in vivo. 
Cytotoxicity (flow 
cytometry) 
Apoptosis  (Cell death 
ELISA; western blot) 
TEM 
(Petit et al. 2006) Co2+: 0–10 ppm  




Co2+ and Cr3+ ions induced a time- and dose-dependent protein 
oxidation, which were inhibited by the antioxidant glutathione 
monoethyl-ester, suggesting that metal ions from MOM 
prostheses have the potential to modify the redox state of cells. 
Nitration of proteins 
(Western blot)  
(Guo et al. 2006) Co2+: 0–200 µM 
 
Acute myeloid 
leukemic cell lines 
NB4 and U937 
macrophages 
Co2+ induced leukemic cell apoptosis with a loss of 
mitochondrial transmembrane potentials, the activation of 
caspase-3/8 and the cleavage of anti-apoptotic protein Mcl-1, 
together with the accumulation of hypoxia-inducible factor-1 
alpha (HIF-1α) protein suggesting a mitochondrial pathway-
dependent and HIF-1alpha-independent mechanisms. 










(Colognato et al. 
2008) 
Co2+:1 0–100 ppm  
  
Human leukocytes Nano-sized cobalt can be internalized by human leukocytes and 
can interact with DNA leading to the observed genotoxic 
effects, which are, however, modulated both by donor's 
characteristics and/or by Co2+ release. 
Genotoxicity (Cytokinesis-
block micronucleus assay; 
Comet assay) 
(Caicedo et al. 
2010) 
Co2+: 0–200 µM 
Cr3+: 0–200 µM 
Human CD14+ 
monocytes 
Soluble cobalt, chromium, molybdenum, and nickel ions and 
CoCrMo particles induce stimulate IL-1β secretion in human 
macrophages that is inflammasome mediated (i.e., NADPH-, 
caspase-1-, Nalp3-, and ASC-dependent).  
Inflammation (ELISA; 
Stealth RNA Interference) 





Co2+ enhanced the secretion of IL-8 and MCP-1 in renal 
epithelial cells, gastric and colon epithelium, monocytes and 
neutrophils, and small airway epithelial cells but not in alveolar 
cells.  
Inflammation (ELISA) 




Cobalt debris was more effective as an inducer of apoptosis and 
NOS2 and BAG1gene expression when cells had been pre-












Dose Cell Type(s) Key Findings and Results Health Endpoint  
(Assay) 




After 14 days, a reduction in the number of CD14+ cells was 
observed in co-cultures exposed to CoCr particles 
CD14+ cell  
reduction (CD14  
staining) 
(Germain et al. 
2003) 
CoCr 29.5 nm 
 
50, 5, 0.5 




The CoCr wear nanoparticles reduced the viability of U937 
cell lines, whereas the micronsized commercial CoCr 
particles did not affect the viability of either cell lines. At 
equivalent particle volumes, CoCr wear particles were more 
toxic than the alumina ceramic wear particles. 
Cytotoxicity (ATP  
level, cell counts 
 
(Williams et al., 
2003) 
CoCr <40 nm 
pin-on-plate 
50, 5, 0.5 




The surface engineered bearings had lower wear compared to 
the CoCr bearings. The wear particles generated from surface 
engineered bearings showed decreased cytotoxicity compared 
to the wear particles generated by CoCr couples. 
Cytotoxicity (ATP  
level) 
(Germain et al. 
2003) 
CoCr 9.87 µm  50, 5, 0.5 




Micron sized CoCr particles did not have significant effect on 
the viability of U937 and L929 cells over 5 days at any of the 
tested concentrations. 
Cytotoxicity (ATP level, 
cell count) 
(Lucarelli et al. 
2004) 
Co 50-200 nm Co (50 
μg/106 cells) 
U937 CoNPs showed significant toxicity at doses higher than 100 
µg/106 cells and had a pro-inflammatory effect on 
macrophages 
Cell viability (MTT) 
Inflammation  
(cytokine level, TLR 
expression) 
(Kaufman et al., 
2008) 
CoCr micron-sized 853 particles per 
cell 
Primary human  
macrophages 
Macrophages cultured with CoCr particles released 




(Caicedo et al. 
2009) 
CoCr 2 µm  5, 10, 20 
particles per cell 
Primary human  
monocytes 
THP-1 
Soluble and particulate metal implant debris induced 
monocyte/macrophage proinflammatory responses. 
Inflammation  
(cytokine level) 
(Kwon et al. 2009) Co 30 nm,  
Cr 30 nm 
1 × 1012 particles 
ml−1 
RAW 264.7 CoNPs and ions induced dose-dependent cytotoxic effects on 
the macrophages. CrNPs showed no significant reduction in 
cell viability at day 1 and 4. 






(Dalal et al., 2012) CoCr 1.1 µm 5, 10, 50, 100 




CoCr particles induced a significant decrease in viability in 





(Caicedo et al., 
2013) 
CoCr (1.1-7.3 µm) 
 
6 µM THP-1 Size and shape of CoCr particles influence phagocytosis, 
lysosomal destabilization, and inflammasome activation. 
Spherical, smooth CoCr particles did not significantly affect 
cytokine production whereas irregular CoCr particles of 
similar size induced significant cytokine production. Larger 
particles induced higher increase in cytokine production 
compared to the smaller particles. Larger, irregular particles 




(VanOs et al., 
2014) 
Cr2O3  




particles per cell 
J774A.1 Although the results displayed low overall cytotoxicity, Cr2O3 
nanoparticles at high concentrations induced significant 
decrease in total cell numbers and significant increase in 
necrosis. The study also showed low levels of cytokine 
production from exposures to these particles. 60 nm and 700 
nm particles caused similar responses to macrophages when 
the doses were normalized by volumes. 




(Posada et al., 
2014) 




/1 × 106 cells 
U937 Cytotoxicity was observed after 48 hours of exposure. 
Apoptosis was also observed at 48 hours. 
Cytotoxicity  
(MTT, Neutral  
Red) 
 
THP-1: human monocyte cell line; U937: human histiocyte cell line; L929: mouse lung fibroblast cell line; MG-63: human osteoblast-like cell 





2.3.2.2 Fibroblast response to CoCr wear particles and ions  
The in vitro response to foreign material has been described as an altered process similar to 
wound healing, during which the body initiates a cascade of events to resolve injury including 
inflammatory, proliferative repair and tissue remodeling (Akay, 2006). This is often refered to 
as the “foreign body response” in the field of biomaterials. The process of the foreign body 
response is a delicate orchestration of signaling involving the participation from numerous cell 
types including immune cells, endothelial cells, epithelium and fibroblasts in the appropriate 
spatial and temporal order. Fibroblasts are one of the central participants during wound healing 
and inflammation. They play a positive role in promoting the recovery of functional tissue but 
equally are capable of driving it towards chronic inflammation, fibrosis or even tissue necrosis 
depending on the biochemical cues they are exposed to.  
For a typical foreign body response to implanted materials, the acute inflammation phase is 
initiated by macrophages. Macrophages phagocytose the foreign body and release a wide range 
of cytokines, which stimulate the proliferation of fibroblasts and recruit fibroblasts to deposit 
extracellular matrix (ECM) proteins such as collagen and fibronectin around the biomaterial to 
form granulation tissues. Fibroblasts actively and dynamically shape the structure of extra 
cellular microenvironments by contracting ECM matrices and secreting ECM proteins such as 
collagen and fibronectin (Tracy et al., 2016). In addition, fibroblasts are known to modulate 
immune cell behaviour by conditioning the local cytokine microenvironment in order to 
balance the inflammatory repair and tissue damage. For example, during remodeling of the 
ECM, fibroblasts enhance the release of various kinds of small peptides, such as Pro-Gly-Pro 
(acetyl-PGP) and tenascin C isoform that have diverse effects on cellular immune responses 
(Vaday and Lider, 2000, Sorokin, 2010). The inappropriate production of these regulatory 
molecules by the activated fibroblasts can prevent the resolution of inflammation, resulting 





Furthermore, in some pathological settings, fibroblasts can express the smooth muscle isoform 
of α-actin (αSMA) that is normally expressed only in smooth muscle cells and become a more 
contractile phenotype: myofibroblasts with enhanced ECM protein synthesis capacities 
(Sappino et al., 1990).  
Understanding of the fibroblast response to wear/corrosion materials is essential to achieve 
desirable long-term outcomes of implanted materials or tissue homeostasis considering the 
indispensable role of fibroblasts play in the biological response to implanted materials. A few 
studies have investigated the effect of CoCr particles and ions on fibroblasts. Papageorgiou et 
al., 2007 exposed primary human dermal fibroblast to CoCr particles in order to study their 
effects on cell viability, integrity and cytokines release. They found that nanoparticles could 
promote free radical formation thus inducing DNA damage and decrease cell viability (Table 
2.7); the CoCr particles were also shown to stimulate the release of IL-6 and TNF-α from 
fibroblasts. Tsaousi et al., 2010 also showed a dose-dependent cytotoxicity and genotoxicity of 
CoCr particles (0.56-4.74 µm). Bhabra et al., 2009 revealed that CoCr nanoparticles 
(29.5 ± 6.3 nm) can induce DNA damage and chromosome aberration in human fibroblasts 
without significant cell death mediated by a novel mechanism involving transmission of purine 
nucleotides (such as ATP) and some other intercellular signaling(Bhabra et al., 2009). 
Although these studies provide useful insights into the cellular response to metal products, they 
mainly focused on the deleterious effects of CoCr particles on fibroblasts. How CoCr particles 
and ions affect fibroblast activation and its functional properties at sub-toxic level remains 
largely unknown. Given the complex and essential role fibroblasts play in the in vitro response 





Table 2.7 In vitro studies of the effect of Co2+ and Cr3+ and CoCr particles on fibroblast  
 
Study Ions/particles  Dose Cell Type(s) Key Findings and Results Health Endpoint (Assay) 
(Germain et al., 
2003) 
CoCr 29.5±6.3 nm 50, 5, 0.5 
and 0.05μm3 per cell  






CoCr 29.5 nm 0.0005 to 5000 μm3/cell Human 
fibroblast cell  
line 
CoCr nanoparticles induced DNA damage and 
cytotoxicity. 
Cytotoxicity (MTT, LDH) 
DNA damage (comet assay) 
Inflammation (cytokine) 
(Bhabra et al., 
2009) 
CoCr 30 nm 0.036 mg cm−2 Primary human  
fibroblast 
CoCr nanoparticles can cause DNA damage 
across a cellular barrier. 
DNA damage (comet, FISH) 









CoCr powders resulted in reduction in cell 
viability. 
Cytotoxicity (Trypan Blue) 
Apoptosis (acridine orange) 




0.1 to 10 mg per T-75 
flask   
Primary human  
fibroblasts 
CoCr particles showed dose-dependent 
cytotoxicity and genotoxicity. 
Cytotoxicity (Trypan Blue) 
DNA damage (micronucleus 
test) 
(Behl et al., 2013) CoCr 40-49 nm  47.6, 23.8, 2.38, 0.238 
and 0.0238 mg/ml 
Porcine fibroblast Co2+ and CoCr nanoparticles induced 
intracellular ROS.  
Cytotoxicity (ATP level) 




CoCr 213-241 nm 0.0005 μm3/cell to 500 
μm3/cell 
Primary human  
fibroblast 
CoCr significant increase in intracellular ROS 
level and induce chromosomal aberrations.  
DNA damage (FISH) 
ROS (DCF) 
(Smith et al., 2014) Co2+, Cobalt oxide 
0.27-3.56 μm 
Co2+: 100-500 µM 
Cobalt oxide: 1-5 µg/cm2 
Human lung 
fibroblast cell line 
Particulate and soluble cobalt are cytotoxic 
and genotoxic to human lung cells. 
Cytotoxicity (crystal violet) 






2.4 Aims of the present study  
Previous studies show that CoCr metal wear debris and dissociated ions induce 
cytotoxicity and inflammation in human macrophage and fibroblast. This involves the 
activation of ROS, MMPs and the release of cytokines such as IL-1β and TNF-α, which 
leads to tissue damage and implant loosening.  
The present study aims to examine how Co2+, Cr3+, CoNPs and CrNPs from CoCr alloys 
influence the behaviour of the local cell populations and related mechanisms. 
Objectives: 
1. The effects of Co2+, Cr3+, CoNPs and CrNPs on macrophage. 
 To determine their toxicity on macrophage viability in vitro. 
 To assess their effects on macrophage motility in vitro and in vivo and underlying 
mechanisms. 
2. The effects of Co2+and Cr3+ on fibroblast. 
 To determine their toxicity on human fibroblast viability in vitro. 
 To identify their effects on fibroblast function in ECM modelling and associated 
mechanisms.  
 To identify the effects on fibroblast activities in the presence of macrophages.  
3. To histologically examine the peri-prosthetic synovial tissues from patients with 
MOM implants and evaluate the activation of synovial fibroblasts from these patients 










Chapter 3. The effects of Co2+, Cr3+, CoNPs and CrNPs 
on macrophage behaviour   
3.1 Introduction   
CoCr wear particles and associated ions produced in peri-prosthetic tissues would 
trigger a wide spectrum of necrotic and inflammatory reactions. The soft-tissue 
reactions have been interpreted and termed, for example, adverse reaction to metal 
debris (ARMD) (Matharu et al., 2016). It occurs as a result of prolonged inflammation 
at the site of an implant, which normally includes a bearing component. Initially, wear 
particles and corrosion products are detected and phagocytosed mainly by tissue-
resident macrophages (Sutphen et al., 2016). When phagocytosis of these wear particles 
occurs in sufficient number, macrophages are activated to release an array of cytokines 
and chemokines to initiate the leucocyte response (Nich et al., 2013). The leukocytes 
infiltrate the inflamed tissue, promote recruitment of inflammatory neutrophils or 
monocytes that differentiate locally into macrophages and potentiate the pro-
inflammatory environment. This response has also be shown to mediated and 
exacerbated by the Co2+ and Cr3+ found in the serum and synovial fluid of patients with 
MoM hip implants (Jennings et al., 2016, Davda et al., 2011).  
Cell migration plays a central role in the maintenance of multicellular functions as well 
as the development of many diseases (Franz et al., 2002). Several studies have 
investigated the effects of nanoparticles on cell migration. TiO2-NPs were shown to 
reduce fibroblast migration by around 59% (Pan et al., 2009).  Au-NPs were shown to 
reduce migration of prostate carcinoma (PC3) cells while the migration of HDF was 





Silica nanoparticles have been reported to be capable of suppressing migration of 
normal human keratinocytes (Wang et al., 2012). However, none of these studies have 
provided a direct mechanistic explanation and the effect of CoNPs on cell migration 
remains unknown.  
The physiological response to a MoM implant has been reported to be either a 
macrophage predominant or a mixed macrophagic and lymphocytic infiltration of soft 
tissue (Sutphen et al., 2016). Macrophages play a decisive role in the innate immunity 
as the first-line immune defense. They are highly motile cells that react rapidly in vivo 
to wounding or inflammatory signals migrating at speeds of over 10 μm/min compared 
with fibroblasts or epithelial cells (~0.1–0.5 μm/min) (Grabher et al., 2007). It is equally 
important that the inflammatory macrophages can migrate out from an inflamed site in 
a controlled and effective manner to prevent undesired macrophage-induced tissue 
damage, granuloma tissue formation and the development of chronic inflammation due 
to excessive macrophage accumulation.  
Co2+ have been shown to enhance inflammatory cells migration in vitro, including 
monocytes and lymphocytes. For example, both Co2+ and Cr3+ have been shown to 
enhance the migration of T lymphocytes independently of circulating cytokines or 
chemokines, but have no effect on B cell motility, resulting in the accumulation of more 
T than B lymphocytes in periprosthetic tissues of some patients with CoCr-based 
implants (Baskey et al., 2017). However, the effect of Co2+ and CoNPs on the 
macrophages’ migration ability, which plays an essential role in the homeostasis of the 






This study aims to reveal the correlation of local exposure to cobalt and chromium 
particulates and ions with the clinical manifestation of a chronic inflammatory response. 
The present study investigate the effect of Co2+, Cr3+, CoNPs and CrNPs on the 
migration of macrophages.  
3.2 Methods 
3.2.1. Particles and ions  
CoNPs and CrNPs purchased from American Elements (Los Angeles, CA, USA). 
CoNPs were composed of 90% cobalt and 10% cobalt (II, III) oxide with a molecular 
weight of 58.93 with a diameter of 2-60 nm (data from the company). CrNPs were in 
the form of chromium oxide (Cr2O3) nanoparticles with a diameter of 10-30 nm 
(manufacturer data).  
Prior to use, the nanoparticles were washed in 100% ethanol for sterilisation and 
resuspended in sterile H20 at a concentration of 1 mg/ml using a sonicator (pulsed mode, 
3 min). Stock solutions (0.1 M) of Co2+ and Cr3+ ions were freshly prepared by 
dissolving CoCl2·6H2O (99.5% purity; Sigma Aldrich) and CrCl3·6H2O (98% purity; 
Sigma Aldrich) in sterile H20. These solutions were sterilized by filtration through 0.2 
μm pore size sterile syringe filter (Merck Millipore). Stock solutions of cobalt and 
chromium nanoparticles and ions were further diluted in cell culture medium prior to 
experiments.       
3.2.2. Characterization of the CoNPs and CrNPs 
Transmission Electron Microscopy (TEM; JEOL JEM-2010, Japan) was employed to 





CrNPs were suspended in pure ethanol and a drop of particle suspension was placed 
onto a carbon coated grid prior to imaging.  
 
Figure 3.1 Transmission electron microscopy image of cobalt and chromium 
nanoparticles. Scale bar=100 µm.   
3.2.3. Cell lines and culture preparation     
3.2.3.1 Human U937 monocytic cell line  
Cells from the U937 cell line (passage 6-25, donation from Dr Akihisa Mitani, Imperial 





supplemented with 10% FBS (Sigma, USA), 1.9 mM L-glutamine, 96 U/ml penicillin, 
96 μg/ml streptomycin, 19 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl] ethanesulfonic 
acid (HEPES) buffer, in a humidified atmosphere with 5% CO2 at 37°C. To induce 
differentiation into adherent macrophage-like cells, cells were treated with 50 ng/ml 
12-tetradecanoate-13-acetate (PMA, Sigma Aldrich) for 48 h, followed by rest for a 
further 24 h in complete RPMI 1640 medium prior to further experiments.  
3.2.3.2 Isolation and differentiation of bone marrow-derived macrophages 
Bone marrow-derived macrophages (BMDMs) (Weischenfeldt and Porse, 2008) were 
isolated and differentiated according to established standard protocols. All mice were 
cared for according to the UK Animal Scientific Procedures Act (1986) and by the 
Institutional Committee for Use and Care of Laboratory Animals. Experiments were 
performed under the UK Home Office Personal licence number I56EDA266 and the 
groups UK Home Office Project Licence number 70/7266.  
Femurs were obtained from 6–12 week old C57BL/6 mice. After euthanasia, the mice 
were sprayed with 70% ethanol and the femurs were dissected using scissors, cutting 
through the tibia below the knee joints as well as through the pelvic bone close to the 
hip joint. Muscles connected to the bone were removed using clean gauze, and the 
femurs were placed into polypropylene tubes containing sterile PBS on ice. In a tissue 
culture hood, the bones were soaked in 70% ethanol for 1 minute, then washed in sterile 
RPMI 1640 medium. The epiphyses were removed by using sterile scissors and forceps, 
the bones were flushed with a 1ml syringe with 25g x 16mm needle (BD Biosciences, 
USA) filled with RPMI 1640 medium to extrude the bone marrow into a 15 mL sterile 
polypropylene tube. The cell suspension generated was fresh bone marrow cells. The 





RPMI1640 supplemented with 10% fetal bovine serum (Gibco, cat. 12657-029), 100 
U/ml penicillin, 100mg/ml streptomycin, 2 mM Lglutamine and M-CSF (50 ng/ml, 
R&D Systems, USA). The cells were seeded in non-tissue culture treated petri dishes 
(BD Biosciences, USA) and incubated at 37°C in a 5% CO2 atmosphere. Four days 
after seeding the cells, an additional 10 ml of fresh medium were added per plate and 
incubated for an additional 3 days. To obtain the BMDM, the supernatants were 
discarded and the attached cells were washed with 10 ml of sterile PBS. 10 ml of ice-
cold PBS was added to each plate and incubated at 4 °C for 10 minutes. The 
differentiated bone marrow macrophages were detached by gently pipetting the PBS 
across the dish. The cells were then centrifuged at 1200 rpm for 5 minutes and 
resuspended in 10 ml of BMDM cultivation media. The cells were counted, seeded and 
cultivated in tissue culture plates for a further 12 hours before any further experimental 
procedure was carried out.  
3.2.4 Cytotoxicity assay 
A colourimetric assay, MTS, was performed to assess the effect Co2+, Cr3+, CoNPs and 
CrNPs on macrophage viability using the CellTiter 96® Aqueous One Solution Cell 
Proliferation Assay (Promega, Southampton, UK). Cells were seeded at a concentration 
of 5×104/well in 96-well plates and exposed to Co2+, Cr3+, CoNPs or Cr NPs. The doses 
ranged from 50 – 350 M for Co2+, 20 – 200 M for CoNPs, 200-800 M for Cr3+ and 
200 – 800 M for CrNP. For vehicle control, cells were stimulated with complete RMPI 
1640 medium.  
After incubation for 6 and 24 h, the medium was aspirated and 100 μl of serum-free 
RPMI medium containing 10% MTS reagent was added to each well. Plates were 





an Infinite F50 plate reader (Tecan, Switzerland). Five replicates of each exposure were 
tested and the entire assay was repeated for three separate experiments. The cell 
viability was determined as a percentage of control cell viability.  
3.2.5 Cell motility and migration assays  
3.2.5.1 Single cell motility monitoring  
The macrophage migratory ability was investigated using live cell imaging. An inverted 
microscope (Lumascope 720, Etaluma, USA) connected to a cell culture incubator was 
used for live cell imaging to visualise macrophage migration. Time-lapse images of 
migrating U937 macrophages at a seeded density of 2×104 cells/cm2 in a 24-well plate 
were collected after 12 h incubation with Co2+ (200 µM), Cr3+ (400 µM), CoNPs (100 
µM) or CrNPs (400 µM). Images were captured every 5 min for 6 h.  
Migratory properties of individual cells (n=25 cells / condition) were identified from 
the time-lapse images and analysed using ImageJ software with "Manual Tracking" 
plugin and Chemotaxis and Migration Tool (ibidi, USA).  
3.2.5.2 Transwell cell migration assay 
Cell migration was also investigated using 6.5 mm Transwell chambers with 8 μm pores 
(Costar, Corning, NY, USA). Briefly, 2×105 harvested U937 macrophages or BMDMs 
in serum free RPMI 1640 medium were added to the upper chamber of the insert. The 
lower chamber was filled with 600 µl RPMI 1640 medium with 10% FBS to encourage 
cell migration down the FBS chemotactic gradient. Cells migration was analysed over 
a 6-hour period in the presence of Co2+ or Cr3+ or following 2-hour pretreatment with 






Table 3.1 Concentration of cobalt and chromium applied for the migration tests  
Treatment Cell type 
U937 macrophages BMDMs 
Co2+ 200 µM 50 µM 
Cr3+ 400 µM 200 µM 
CoNPs 100 µM 20 µM 
CrNPs 400 µM 200 µM 
 
3.2.6 In vivo macrophage efflux model  
To demonstrate the in vivo effect of cobalt on mouse macrophage migration, 20 WT 
C57BL/6 mice were first injected intraperitoneally with 1 ml of 4% thioglycollate 
(Sigma, USA) to recruit macrophages into the peritoneal cavity. Thioglycollate solution 
was wrapped with aluminum foil and placed at room temperature to age for 3 weeks by 
when it turned to brown in color. This aging process is essential to enable the 
thioglycollate solution to effectively induce peritonitis. After 4 days, the mice were 
injected intraperitoneally with 5 µg of CoNPs (10 mice) or PBS (10 control mice). After 
12 h, peritoneal cells from 5 mice from each group were harvested to quantify the 
number of macrophages. The remaining 5 mice from each group were injected with 
LPS (250 μl; 5 μg/ml) to induce macrophages migration/efflux towards regional lymph 






Figure 3.2 Illustration of in vivo macrophage migration model. 
3.2.7 Fluorescence-activated cell sorting (FACS) analysis  
The macrophages harvested as described in 3.2.3.2 were quantified by flow cytometry. 
The collected cell suspensions were transferred to FACS tubes (BD Biosciences; 
Oxford, UK), centrifuged for 5min at 350g and the supernatant was then aspirated. Cell 
suspensions were pre-incubated with anti–CD16/CD32 mAb (BD Pharmingen) in 
FACS buffer to block Fcγ R II/III receptors, which bind antibody-antigen immune 
complexes, on ice for 15 min to identify any non-specific binding. All the tubes were 
then gently vortexed and left for 15 min in the dark at room temperature. After 
centrifugation and washing, cells were stained with PE/Cy5 anti-mouse CD11b 
antibody (Abcam, UK) and FITC anti-mouse F4/80 antibody (Abcam, UK). Stained 
cells were washed and re-suspended in 200 μl of PBS and analysed using a flow 






Table 3.2 Monoclonal antibodies used to assess murine macrophages.  
Antibody Purpose 
anti-mouse CD11b-PE/Cy5 Expressed on leukocytes 
anti-mouse F4/80-FITC Expressed on murine macrophage 
 
3.2.8 Data analysis 
Normality testing (Kolmogorov-Smirnov test) was performed for all experimental data. 
All data are expressed as the median or mean ± SEM from separate experiments. The 
number of replicates per experiment (n) is indicated in the figure. Statistical analysis 
was conducted with SPSS (Inc., Chicago, IL, USA) for each assays are listed in Table 3.3. 
Table 3.3 Statistics methods for each assays. 
Experiments  Statistics methods 
Cell viability test one-way ANOVA with Bonferroni post-hoc t-test 
Random migration assays one-way ANOVA with Bonferroni post-hoc t-test 
Transmigration  assays one-way ANOVA with Bonferroni post-hoc t-test 








3.3 Results  
3.3.1 Activation of U937 cells with PMA 
In this study, U937 cells were exposed to 50 ng/ml PMA for 2 days with the medium 
changed and then left for one more day to recover from PMA treatment. The alteration 
in cell aggregation and adhesion, recorded every 24 hours by imaging the culture cells, 
are shown in Figure 3.3 Although U937 cells are non-adherent cells, they tend to 
sediment and sit at the bottom of the well forming a homogenous layer (Figure 3.3A). 
It can be seen that when cells were treated with PMA for 2 days (Figure 3.3B), cell 
aggregates, characteristic of the differentiation of U937 cells, were formed. 
 
Figure 3.3 Differentiation of U937 cells. A: Untreated U937; B: U937 cells activated 
with PMA for two days. Images acquired using an optical microscope (DCF420, Leica, 









3.3.2 The effects of Co2+, Cr3+, CoNPs and CrNPs on U937 macrophages viability  
The viability of differentiated U937 cells following exposure to Co2+ and CoNPs over 
6 and 24 hours measured with MTS assay are shown in Figure 3.4. Co2+, in 
concentrations ranging from 50 to 350 µM, had no significant effect on U937 cell 
viability after 24 hours of treatment. CoNPs cytotoxicity evaluated in concentrations 
ranging from 20 to 100 µM had no obvious effect on U937 macrophages viability 
(Figure 3.4). While CoNPs started to show an effect on U937 macrophages at a 
concentration of 150 µM, which reduced cell viability by approximately 25%. However, 
this reduction was not visible after 24 hours. 200 µM of CoNPs caused an 
approximately 30% reduction in cell viability at 6 hour and this effect remained 
significant after 24 hours. In addition, Cr3+ and CrNPs up to 800 µM had limited effect 
on U937 cell viability.      
 
Figure 3.4 Effect of Co2+ and CoNPs on U937 cell viability at 6 and 24 hours with the 
MTS assay. Data represents mean +SEM, n=9 from 3 independent experiments. 







3.3.2 The effects of Co2+, Cr3+, CoNPs and CrNPs on BMDMs viability  
In general, Co2+ and CoNPs caused a concentration-dependent cytotoxicity in the 
BMDMs (Figure 3.5). Co2+ at concentrations below 100 µM and CoNPs less than 40 
µM had no significant effect on the BMDMs viability over 24 hours, which was thereby 
deemed to be non-toxic. 150 µM of Co2+ and 60 µM of CoNPs induced a significant 
decrease in cell viability, to approximately 80% after 24 hours, falling to approximately 
60% at the highest concentrations applied (200 µM Co or 80 µM CoNPs). Therefore, 
the cytotoxicity results indicate that Co2+ and CoNPs at high doses could cause early, 
or acute adverse cell response and cell death. Similarly, Cr3+ and CrNPs did not shown 
any significant effect on BMDMs viability.  
 
Figure 3.5 Cytotoxic effect of Co2+ and CoNPs on the BMDMs viability at 6 and 24 
hours. Data represents mean +SEM, n=9 from 3 independent experiments. Statistically 








3.3.4 Co2+ and CoNPs inhibit U937 macrophage random migration 
To directly measure the impact of cobalt and chromium on macrophage motility in vitro, 
time-lapse imaging of U937 macrophages after 6 hours of cobalt or chromium treatment 
using non-cytotoxic concentrations (Table 3.1) based on cell viability testing (Figure 
3.4) was performed. Figure 3.6 A-E shows the migration paths for 25 individual cells 
in each treatment group over 6 hours of observation. The total path length of cells 
treated with Co2+ and CoNPs was significantly shorter than those for untreated control 
cells (p<0.001, Figure. 3.6F). Treatment with Cr3+ or CrNPs had no significant effect 
on macrophage migration length.  
 
Figure 3.6 Co2+ and CoNPs reduce U937 macrophage random migration. (A-E): 
Detailed migration trajectories of cells (n=25) over a 6-hour period following treatment 
with cobalt or chromium. Individual tracks were transposed so that each of the cells 
started at the same origin. (F) Net cell migration length for each treatment with values 
indicating mean +SEM from 3 independent experiments (n=75 cells/condition). 
Statistically significant differences are indicated relative to untreated control; 







3.3.5 Co2+ and CoNPs inhibits U937 macrophages transmigration   
Using the transwell migration assay, the results observed from the cell random 
migration assay (Figure 3.6) were confirmed. The ability of U937 macrophages to 
migrate through the porous transwell membrane was significantly impaired by pre-
treatment with either Co2+ or CoNPs (Figure. 3.7). Exposure to Co2+ and CoNPs, 
reduced the number of transmigrating cells by approximately 62% and 55%, 
respectively. While CoNPs caused a slightly reduction in cell migration, the difference 
was not statistically significant. Incubation with Cr3+ had no obvious effect on the cell 
migration relative to untreated controls for U937 macrophages. 
 
Figure 3.7 Co2+ and CoNPs reduce transmigration of U937 macrophages. 
Representative images of migrated U937 macrophages treated by Co2+, CoNPs, Cr3+ 
and CrNPs (Scale bar = 100 µm) and quantifications of the migration assay based on 
three independent experiments. Values represent mean + SEM. n=30 from 3 
independent experiments; 10 random fields were imaged for each treatment in each 
experiment. Statistically significant differences are indicated relative to untreated 






3.3.6 Cobalt inhibits BMDMs transmigration   
In BMDMs, the corresponding reduction in migration was approximately 45% and 53% 
for Co2+ and CoNPs, respectively (Figure 3.8). In addition, incubation with Cr3+ and 
CrNPs had no statistically significant effect on the cell migration relative to untreated 
controls. 
 
Figure 3.8 Co2+ and CoNPs reduce transmigration of BMDMs. Representative images 
of migrated BMDMs treated by Co2+, CoNPs, Cr3+ and CrNPs (Scale bar = 100 µm) 
and quantifications of the migration assay based on three independent experiments. 
Values represent mean + SEM. n=30 cells from 3 independent experiments (10 random 
fields were imaged for each treatment in each experiment). Statistically significant 









3.3.6 CoNPs inhibit macrophage migration in vivo 
To study the effect of CoNPs on macrophage migration in vivo, the number of 
macrophages in the mouse peritoneal cavity before and after LPS stimulation with or 
without 5 µg CoNPs treatment were quantified. Harvested peritoneal macrophages 
were identified by a flow cytometry gating strategy according to their size and 
granularity (Figure 3.9A), CD11b and F4/80 surface marker expression (Figure 3.9B).   
 
Figure 3.9 Gating strategy of FACS analysis to identify mouse peritoneal macrophages. 
Representative FACS analysis images showing the gating strategy to identify the 
peritoneal macrophages based on (A) cell size, cell granularity, (B) CD11b and F4/80 










In the absence of LPS stimulation, no any significant change to the number of peritoneal 
macrophages following 12 hours of CoNPs pre-treatment when compared to the PBS 
control was observed. In control mice (PBS-treatment), LPS stimulation significantly 
increased the efflux of peritoneal macrophages (Figure 3.10) from the cavity, with a 
reduction of the number of macrophages to 40% of the control, consistent with 
previously published work (Park et al., 2009). Following CoNPs pre-treatment, the 
number of macrophages was not greatly affected by LPS stimulation (95% of the 
control) and remained at similar levels to the CoNPs pre-treatment alone (115%). In 
summary, CoNPs inhibited murine peritoneal macrophages migrating out from the 
cavity. 
 
Figure 3.10 Macrophage migration in vivo is inhibited by CoNPs. Figure showing the 
number of harvested macrophages from treated mouse from each group. Data 
normalised to PBS control. n = 5 mice per treatment, ** indicates difference from PBS 
control P < 0.01; # indicates difference between CoNPs treatment and corresponding 








3.4 Discussion  
A wide range of in vivo and in vitro studies have been conducted to elucidate the 
contributing factors and mechanism underline the pathogenesis of ALTRs due to CoCr 
exposure. This chapter has described a combined in vitro and in vivo approach to 
examine the differential response of macrophages to both cobalt and chromium ions 
and associated nanoparticles. Here, rather than focusing on what doses of Co2+ and 
CoNPs induce cell apoptosis or trigger inflammatory response, this study has focused 
on how metal ions and particles exposure alter macrophages migration at relatively 
modest levels.    
It has been well established that both CoCr ions and nanoparticles are cytotoxic and 
able to trigger apoptosis or necrosis in a dose and time-dependent manner 
(Papageorgiou et al., 2007, Nyga et al., 2015, Petit et al., 2006, Catelas et al., 2005, 
Posada et al., 2014). Metallic debris has been shown to promote macrophage activation 
and trigger the release of an array of proinflammatory mediators, such as TNF-α, IL-
1β, IL-6, IL-8 and interferon (IFN)-γ (Caicedo et al., 2010, Kaufman et al., 2008). 
The present in vitro results revealed that both Co2+ and CoNPs markedly inhibit the 
random migration and chemotaxis of both U937 macrophages as well as murine bone 
marrow derived macrophages (BMDMs), while Cr3+ and CrNPs had no statistically 
significant effect. These results were further confirmed in vivo. Previously, in vivo 
studies have generally been performed by directly injecting micro-size CoCr particles 
into knees or muscles of rats and/or guinea pigs from a few days to months and 
investigating the tumor formation or abnormal findings during gross examination of the 
animals (Brown et al., 2007). For the first time, a peritoneal macrophage efflux model 





emigration from the cavity triggered by LPS was significantly inhibited (Figure 3.10), 
supporting the in vitro findings. These findings suggest that the extensive clinical issues 
associated with implants manufactured from CoCr alloys could be associated with 
macrophage retention in the peri-prostheses area due to impaired cell migratory ability. 
Cell migration plays a critical role in many cellular process, such as embryogenesis, 
wound healing or immune response (Mayor and Etienne-Manneville, 2016). It has been 
reported that metal ions and NPs are able to alter the speed of the cell motility. Co2+ 
and Cr3+ have been shown to enhance the migration of T lymphocytes. Beryllium (Be2+), 
known as a metal sensitizer, can also stimulate lymphocyte migration (Klein et al., 
2006).  The contributing factors for the enhanced cell migration was not provided in 
these studies. Also, one study examined the chemotactic effects of Co2+ and Cr3+ on 
human neutrophils via monitoring cell movement through agarose gels (Williams, 
1989). Their results suggested that cobalt and chromium ions are not chemotactic for 
human neutrophils. On the other hand, a variety of NPs are showed to have an effect 
on cell motility.  For example, the speed of A549 cell movement was reduced by SiO2 
NP treatment due to the disruption of cytoskeleton structure (Gonzalez et al., 2015). In 
addition, SiO2 and TiO2 treatments have been shown to increased cell adhesion, cell 
traction and reduce migration of TR146 cells in a dose-dependent manner, which is also 
associated with alteration in cytoskeleton (Tay et al., 2014a). However, treatment of 
MSC cells with TiO2 have been shown to impair cell adhesion and lead to reduced cell 
migration, as, without proper adhesion, cells are not be able to exert sufficient traction 
force to pull the cells forward in order to initiate migration (Hou et al., 2013). In all, the 
effects of metal ions and NPs on cytoskeleton organization and cell-ECM interaction 
play essential roles in promoting or hampering cell migration. In the light of this, 





molecular signalling pathway will be investigated in the next chapter to elucidate the 



























Chapter 4. Cytoskeleton remodelling and associated 
signalling pathway activation resulting from Co2+, Cr3+, 
CoNPs and CrNPs treatment  
4.1 Introduction 
By applying a range of in vitro and in vivo migration assays, chapter 3 demonstrated 
that Co2+ and CoNPs, reduced macrophage migration capacity, while Cr3+ and CrNPs 
had limited effects. In response to tissue damage or infection, macrophages have the 
ability to quickly change their shape and move. To initiate cell migration, internal forces 
are developed by the actin cytoskeleton and transmitted through cell-substrate adhesion 
sites coupled with the dynamic turnover of adhesion complexes (Mayor and Etienne-
Manneville, 2016). Generally, cell migration includes the steps illustrated 
schematically in Figure 4.1.  
1. In response to the guidance cue in the extracellular environment, cells form short 
surface protrusions, termed filopodia or microspike supported by a core of bundled 
actin filaments (microfilaments) at the front.  In macrophages, filopodia support a 
thin sheet of membrane-enclosed cytoplasm, known as lamellipodia, containing a 
meshwork of myosin II-associated microfilaments.  
2. New adhesion points are then formed in the front of cell for attachment to the ECM.  
3. Actomyosin activity is enhanced to promote the retraction of the rear.  
4. Finally, the whole cell body is enable to move forward via disassembly of the 






Figure 4.1 Illustration of the basic steps during 2D cell migration. (Adapted from 
https://www.mechanobio.info).  
 
While the actin cytoskeleton provides the driving force for cell migration, the 
microtubule network is known to play a critical role in regulating cell polarity (Ridley 
et al., 2003).  Studies concerning the correlation between the actin and microtubule 
structure have also indicated that these two polymers are closely connected via 
signalling molecules and intermediate proteins either directly or indirectly (Etienne-
Manneville, 2004).  
Therefore, in this chapter, a wide range of techniques were applied to unravel the effects 
of Co2+ and CoNPs on macrophage cytoskeleton organization and associated signalling 







4.2.1 Immunofluorescence confocal and super resolution microscopy 
Cobalt and chromium-treated U937 macrophages and BMDMs were fixed with 4% 
paraformaldehyde (Sigma, USA) and washed and permeabilized with 0.5% Triton X-
100 and rinsed 3 times with PBS. Nonspecific binding sites were blocked by adding 
PBS with 1% BSA. The adhesion protein, vinculin, was labelled by incubation at 4°C, 
overnight with mouse monoclonal anti-vinculin primary antibody, clone hVIN-1 (1:400, 
Sigma, USA). Cells were then washed and incubated for 1 h at room temperature in 
Alexa 488 conjugated anti-Mouse IgG as Secondary Antibody (1:1000, Invitrogen, 
USA). In separate samples, cellular α-tubulin and acetylated α-tubulin were labelled 
using rabbit polyclonal anti-α tubulin antibody (1:200, Abcam, UK) and mouse anti-
acetylated tubulin, clone 611B-1 (1:2000; Sigma-Aldrich, USA) respectively with 
Alexa 488 secondary antibodies as above. 
To simultaneously label the F-actin, the samples were incubated for 30 mins with 200 
μl of rhodamine-conjugated phalloidin (Molecular Probes, USA) in a humidified 
chamber at room temperature in the dark. Cell nuclei were stained by incubation with 
5 μg/ml DAPI (Dojindo) followed by two PBS rinses. Slides were then visualized with 
a fluorescence microscope (Leica SP2) with x63 objective. Slides were also imaged on 
a microscope (Zeiss 710 ELYRA PS.1) with a ×63/1.4 NA objective for structural 
illumination microscopy.  
4.2.2 Protein extraction and Immunoblotting 
All lysis buffers were supplemented with 1% protease inhibitor (Sigma Aldrich, USA).  
Protein extracts were resolved  using  gradient  precast SDS – polyacrylamide gel 





nitrocellulose membrane by using Trans-Blot® Turbo™ Transfer System (Biorad 
Laboratories Inc, USA) for immunoblot analysis. Antibody probing was performed as 
per manufacturers’ instructions. Secondary antibodies either IRDye® 800CW Goat 
anti-Mouse IgG (LI-COR, USA) or IRDye® 800CW Goat anti-Rabbit IgG (LI-COR, 
USA) were used with dilution of 1:10000. Specific protein bands were detected using 
Odyssey® CLx Imaging System (LI-COR, USA). Images of protein bands were 
analysed as depicted in Appendix I.  
4.2.3 Scanning electron microscope (SEM) analysis 
U937 macrophages treated by Co2+ (200 µM), CoNPs (100 µM), Cr3+ (400 µM) or 
CrNPs (400 µM) for 12 hours were fixed in 2.5% glutaraldehyde (Sigma, USA) for 2 
h and dehydrated in graded ethanol (50%, 70%, 80%, 90%, 95%, and 100%; 10 min 
for each). The samples were transferred to critical-point drying with 
hexamethyldisilazane (Sigma, USA) then coated with a 5 nm thick layer of gold–
palladium alloy. The SEM images were obtained with a scanning electron microscope 
(FEI Quanta 200) at a low voltage (∼1 kV).    
4.2.4 Immunofluorescent images analysis  
Immunofluorescent images were analysed by using imageJ (NIH, USA) (Schindelin et 
al., 2012). To quantify cell area, the original image (Figure 4.2A) for the F-actin channel 
was converted to 8 bits and binary images (Figure 4.2B). Individual cells were defined 
as region of interest (ROI) to measure cell area using Analyze Particles tool in imageJ. 
For quantification of podosomes, the image (Figure 4.2D) was first smoothed to reduce 
the background noise (Figure 4.2E). The images were similarly converted to binary 
(Figure 4.2F) with adjacent objects segmented using the Watershed function. The 





Analyze Particles tool and counted with the Find Maxima tool in ImageJ (Cervero et 
al., 2013).  
 
Figure 4.2 Fluorescence images showing the method applied to quantify cell area and 
podosomes in individual cell with ImageJ step by step. 
 
4.2.5 Cell adhesion assay  
U937 macrophages were seeded at a concentration of 2×105 cells/well into a 24-well 
plastic cell culture plate coated with 2% gelatin and treated with 100 µM, 200 µM or 
300 µM Co2+. After 30 min of incubation, cell culture medium in each well was 
aspirated and gently rinsed twice with warm PBS. Adherent cells were then imaged (10 
fields of each well were randomly selected) with an inverted microscope (DCF420, 
Leica, Germany) and counted.  
4.2.6 In vitro ECM degradation assay 





Cells were seeded onto coverslips that were coated with FITC-conjugated gelatin as 
part of an in vitro ECM degradation assay, as described in Figure 4.3. Briefly, glass 
coverslips were coated with 0.2 mg/ml FITC-gelatin (Molecular Probes) in PBS and 
fixed with 0.5 % glutaraldehyde, washed six times with PBS, then washed once with 
70% ethanol/PBS and once with medium.  
 
Figure 4.3 Schematic demonstrating the individual steps involved in preparing glass 
coverslips for gelatin matrix coating. Steps conducted in the light (lit bulb) and in the 
dark (non-illuminated bulb) are cartoon indicated. Steps conducted in the dark help 
prevent photobleaching of the fluorescent matrices. 
 
Matrix degradation activity quantification  
U937 macrophages (1 × 105) were plated onto the coverslips and incubated at 37 °C for 
24 h, then fixed, processed for F-actin staining with rhodamine-conjugated phalloidin, 
and observed as described above. The coverslips were examined using a Leica SP2 
confocal microscope and the total area that was degraded was measured using ImageJ 





areas of gelatin matrix degraded by treated cells to the area of gelatin matrix degraded 
by untreated cells. 
 
Figure 4.4 Images demonstrating key steps in computational-assisted quantification of 
normalized gelatin degradation. (A) Image of FITC-conjugated gelatin, showing dark 
areas (arrows) where degradation has occurred. (B) 8-bit image converted from A. (C) 
Thresholded gelatin image highlighting areas of degradation, which would be measured 
by imageJ software. 
 
4.2.7 Gelatin zymography 
Conditioned media collected from cells treated by Co2+ and CoNPs were used for 
gelatin zymography to measure MMPs activities. The supernatants were subjected to 
electrophoresis in an 8% SDS-PAGE gel co-polymerized with gelatin (1 mg/ml, Sigma, 
USA). The gelatinolytic activities were detected as transparent bands against the 
background of Coomassie Brilliant Blue-stained gelatin and quantified using ImageJ 
software.  
4.2.8 ROS measurements 
ROS formation was measured using 5-(and 6-)-chloromethyl-2’7’-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Life technologies, USA). Cells 
were cultured in black 96-well plates with a clear bottom. After exposure, the 





H2DCFDA was dissolved in anhydrous DMSO to a final concentration of 1 mM and 
diluted further in Hank's balanced salt solution (HBSS, ThermoFisher, USA). Cells 
were exposed to 1 μM CM-H2DCFDA for 30 min at 37 °C in the dark. Fluorescence 
was read at excitation 485/20 nm with emission 528/20 nm using a microplate reader 
(Synergy HT Multi-Mode).  
4.2.9 Data analysis 
Normality testing (Kolmogorov-Smirnov test) was performed for all experimental data. 
All data are expressed as the median or mean ± SEM from independent repeat 
experiments (N=3). The number of repeat measurement per experiment (n) is indicated 
for each figure. Statistics analysis conducted with SPSS (Inc., Chicago, IL, USA) for each 
assays are listed in Table 4.1. 
Table 4.1 Statistics methods for each assays. 
Experiments  Statistics methods 
Fluorescent signal intensity 
measurement 
one-way ANOVA with Bonferroni post-hoc t-test 
Protein expression analysis 
via western blot  
one-way ANOVA with Bonferroni post-hoc t-test 
Transmigration  assays one-way ANOVA with Bonferroni post-hoc t-test 
Quantification of podosome 
number and podosome 
density. 
Kruskal-Wallis test and Dunn's post-test  
Podosome formation in Co2+-
treated cells with or without 
NAC  
Mann-Whitney U test 
Percentages of cells forming 
podosomes projected cell 
area quantification  
one-way ANOVA with Bonferroni post-hoc t-test 
Cell adhesion analysis  one way ANOVA and Bonferroni post-hoc t-test 
Zymography assay one-way ANOVA with Bonferroni post-hoc t-test 






4.3 Results  
4.3.1 Modulation of cobalt and chromium on microtubule acetylation in U937 
macrophages  
4.3.1.1 Influence of Co2+ and CoNPs on microtubule acetylation in U937 macrophages  
Uptake of metal particles are known to impede the force balance between the 
microtubule and F-actin by inhibiting MT polymerization (Mayor and Etienne-
Manneville, 2016). Therefore whether the inhibition of macrophage migration is caused 
by microtubule or cytoskeletal impairment was investigated.  
The structure of the microtubules for the untreated and treated cells are shown in Figure 
4.5A. It is evident that exposure to Co2+ and CoNPs induced a substantial increase in 
U937 macrophage tubulin acetylation based on the fluorescent signal of immuolabeled 
acetylated-α-tubulin (Ac-tubulin, Figure 4.5A), the basic component for microtubule 
biopolymer (Akhmanova and Steinmetz, 2015). Further quantification of the 
fluorescent intensity of acetylated α-tubulin relative to α-tubulin (Figure 4.5B) showed 
a significant increase in the acetylation of tubulin when macrophages were treated by 
Co2+ and CoNPs (~90% and ~50% increase respectively). Cr and CrNPs did not have 
an obvious effect on the acetylation of tubulin in macrophages (Figure 4.5). Tubastatin 





               
Figure 4.5 Cobalt induces hyper-acetylation of alpha tubulin. (A) Representative 
immunofluorescence confocal images of U937 macrophages treated with Co2+, CoNPs, 
Cr3+, CrNPs and Tubastatin A. Cells were stained for acetylated α-tubulin (red) and α-
tubulin (green). Scale bar represents 20 µm. Integrated fluorescent signal intensity for 
acetylated and non-acetylated tubulin in each cell was quantified and shown in (B); 
values represent mean +SEM; n=75 cells for Co2+, CoNPs, Cr3+, CrNPs and Tubastatin 






Further protein expression analysis revealed a consistent increase in acetylated a-
tubulin of Co2+ and CoNPs-treated cell (Figure 4.6). By contrast, chromium had no 
significant effect on microtubule organisation or acetylation.  
    
Figure 4.6 Cobalt induces hyper-acetylation of alpha tubulin at protein level. (A) 
Western blots results for acetylated α-tubulin and α-tubulin for cells treated with cobalt, 
chromium, Tubastatin A and (B) the corresponding quantification demonstrating 
increased total α-tubulin acetylation. Values represent mean +SEM; n=6 replicates for 
Co2+, CoNPs, Cr3+ and CrNPs treatment from 3 independent experiments (2 
replicates/experiment); n=4 replicates for Tubastatin A treatment from 2 independent 
experiments (2 replicates/experiment); */*** indicate difference from control, 











4.3.1.2 The effect of microtubule acetylation on U937 macrophages migration 
Overexpression of HDAC6 (Histone deacetylase 6), which induces a global 
deacetylation of alpha-tubulin, promotes NIH-3T3 cell chemotactic migration (Hubbert 
et al., 2002). Similarily, Tubastatin A treatment caused a statistically significant 
reduction in the number of migrated U937 macrophages quantified using the transwell 
migration assay, which partially replicated the effect of cobalt treatment (Figure 4.7). 
However, while Tubastatin A induced a greater degree of increase in tubulin acetylation 
compared to exposure to Co2+ (Figure 4.6B, p< 0.001), it did not have a parallel impact 
on macrophage migration (Figure 4.7). This suggests that cobalt-mediated tubulin 
acetylation in macrophages does not play a decisive role in downregulation of cell 
migration resulted from cobalt challenge.   
  
Figure 4.7 The effect of Tubastatin A on macrophage migration compared with Co2+ 
treatment. Increased tubulin acetylation with Tubastatin A significantly reduced 
macrophage transwell migration partially replicating the effect of cobalt treatment. 
Values represent mean+SEM; 10 random fields were imaged for each treatment in each 








4.3.2 Cobalt promotes F-actin cytoskeleton remodelling of U937 macrophages 
Unlike some other adherent cell lines, instead of forming actin stress fibres, 
macrophages produce podosomes, which comprise of a F-actin core, surrounded by a 
ring of adhesion receptors and actin-associated proteins (Evans and Matsudaira, 2006). 
U937 macrophages were shown to express characteristic podosome-like punctate 
adhesion structures, characterised by an actin-rich core surrounded adhesion proteins, 
for example, vinculin. Treatment with both Co2+ and CoNPs dramatically enhanced 
podosome formation. (Figure. 4.8).   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
 
Figure 4.8 Co2+ and CoNPs promote podosome formation. Representative confocal 
microscopy images showing appearance of punctate podosome adhesion structures 
consisting of actin core (red) and surrounded by vinculin (green) in U937 macrophages 





Treatment with both Co2+ and CoNPs significantly increased the number podosome 
(Figure 4.9A), the density within individual cells (Figure 4.9B) and the percentage of 
cell showing podosomes (Figure 4.9C). Quantification of cell projected area revealed 
that Co2+ and CoNPs also led to marked cell spreading with a significant increase 
(p<0.001) in cell size (Figure 4.9D). 
 
Figure 4.9 Co2+ and CoNPs promote podosome formation. Quantification of (A) 
Podosome number/cell; (B) Podosome density; data with median shown from one 
representative experiment out of three; n=200; ***p < 0.001. (C) Percentages of cells 
forming podosomes in different group and (D) Projected cell area for each treatment. 









4.3.3 Cobalt induces macrophage morphology change   
Consistent with F-actin cytoskeleton labelling, as shown by SEM images, Co2+ and 
CoNPs promoted drastic changes in the U937 macrophage morphology with marked 
cell spreading and increased lamellipodia protrusions projected around the cell 
periphery (Fig. 4.10).  
 
Figure 4.10  Representative SEM images of U937 macrophages incubated for 12 h with 
Co2+ (200 µM), CoNPs (100 µM), Cr3+ (400 µM) or CrNPs (400 µM) and untreated 
control. Scale bar indicates 100 µm. 
 
4.3.4 Cobalt promotes podosome formation in BMDMs 
While cell area is not statistically different among different treatment groups (Figure 
4.11A), treatment with both Co2+ and CoNPs significantly increased the percentages of 
cells showing podosomes. While around 24% of untreated BMDMs presented 
podosome structure, Co2+ and CoNPs exposure induced approximately 46% and 
approximately 40% BMDMs respectively to form podosomes (Figure 4.11 B,C). 
Similarly, neither Cr3+ nor CrNPs showed an obvious effect on cytoskeleton 






Figure 4.11 Cobalt increases the percentages of cells forming podosomes in BMDMs, 
(A) Quantification of alteration in cell area. (B) Percentages of cell forming podosmes 
in BMDMs after treatments; arrows: podosomes in BMDMs; Vales represent mean + 
SEM, n=300 cells from 3 independent experiments (100 cells/experiment); *p < 0.05, 
**p < 0.01. (C) Staining and of podosome formation; arrows: podosome structure. 
Scale bar indicates 10 µm.    
 
4.3.5 Co2+ enhance cell adhesion in a dose-dependent manner  
It is known that an excessive formation of adhesion complexes could result in the strong 
anchorage of cells to the underlying substrate, which can lead to inhibited cell migration 
(Osma-Garcia et al., 2016). Thus, whether changes in morphology and podosome 
formation due to cobalt treatment, were associated with alterations in cell adhesion was 
examined. Treatment with Co2+ enhanced U937 macrophage adhesion, to extracellular 





(Figure 4.12). Collectively, these results indicated that the cobalt-induced reduction in 
migration were associated with cytoskeletal reorganisation, podosome formation and 
increased cell adhesion. 
 
 
Figure 4.12 (A) Representative bright-field of view images showing that cobalt 
increased cell adhesion to ECM in a dose-dependent manner, where the scale bar 
indicates 100 µm, as quantified in (B) by significantly increased numbers of adherent 
cells per field of view at 200 μM and 300 μM. Values represent mean + SEM. n=30 
from 3 independent experiments; 10 random fields were imaged for each treatment in 
each experiment; *p < 0.05, **p < 0.01.  
 
4.3.6 Cobalt-induced podosome formation in U937 macrophages stimulates ECM 
degradation 
4.3.6.1 Cobalt enhance ECM degradation by U937 macrophages  
Podosomes promote adhesion to the substrate and degrade the components of the 
extracellular matrix. To determine whether cobalt-induced podosomes are able to 





loss of FITC-conjugated gelatin was performed. Macrophages induced localised 
degradation as shown by dark areas in the fluorescent-tagged gelatin matrix (indicated 
by arrows in Figure 4.13A). The degradation of gelatin were closely associated with 
cells expressing podosomes. In some cases, the podosomes were located directly over 
the degraded matrix based on confocal images (Figure 4.13A) and fluorescent intensity 
measurement (Figure 4.13B).  
       
Figure 4.13 Podosome formation in U937 macrophages is associated with ECM 
degradation. (A) Representative fluorescence microscopy image showing FITC-
conjugated gelatin (green) degraded by U937 macrophages counter stained for F-actin 
(red) podosomes. (B) Associated fluorescence intensity measurement demonstrates the 
co-localization of areas of gelatin degradation and the F-actin podosomes. Scale bar 









Both Co2+ and CoNPs promoted matrix degradation as shown by representative images 
in Figure 4.14A, with associated statistically significant differences in matrix 
degradation index (Figure 4.14B). Treatment with Cr3+ and CrNPs had limited effects 
on degradation. 
 
Figure 4.14 Enhanced ECM degradation is induced by Co2+ and CoNPs. (A) 
Representative images showing FITC-conjugated gelatin degradation following 24 h 
treatment with Co2+ (200 µM), CoNPs (100 µM), Cr3+ (400 µM) or CrNPs (400 µM) 
and untreated control. (B) Associated measurements of degradation area quantified as 
degradation index normalized to control group show significantly increased 
degradation following cobalt treatments. Values represent mean + SEM. n=30 from 3 
independent experiments; 10 random fields were imaged for each treatment in each 





4.3.6.2 Cobalt stimulates MMP9 release and activation in U937 macrophages, which is 
co-localized with podosome formation 
The matrix degradation by podosomes involves the recruitment and activation of matrix 
metalloproteinases (MMPs) (Linder and Aepfelbacher, 2003). Using a zymography 
assay, the release and activation of MMP2 and MMP9 was measured. It was observed 
that the release of MMP9 (bands at a molecular weight of 82-92 kDa) was increased 
after cobalt stimulation (Figure 4.15A). Additionally, a lower band of 82 kDa molecular 
weight was observed indicating an active form of MMP9 cleaved from pro-MMP9. Pro-
MMP9 release was not dose-dependent, while both Co2+ and CoNPs induced a dose-
dependent increase in the formation of active MMP9 (Figure 4.15B, C). Cobalt 
exposure had no significant effect on MMP2 release (Figure 4.15B, C).  
 
Figure 4.15 Enhanced ECM degradation induced by cobalt is associated with the release 
and activation of MMP9, which co-localizes with podosomes. (A) Zymography gels 
showing the release and activation of MMP9 by U937 cells due to cobalt treatment. (B 
& C) Quantification of the formation of pro-MMP9, active MMP9 and MMP2 based 
on gelatin zymography results, Values represent mean+SEM; n=6 replicates for each 
treatment from 3 independent experiments (2 replicates/experiment). *p < 0.05, 





Immunofluorescent staining revealed that intracellular MMP9 frequently co-localised 
with cobalt-induced podosomes (Figure 4.16). 
 
Figure 4.16 Confocal immunofluorescence localisation of MMP-9 (green) in U937 
macrophages after cobalt treatment (200 µM Co2+ and 100 µM CoNPs) reveal co-
localisation with F-actin podosomes (red). Scale bar indicates 20 μm.   
 
4.3.7 Cobalt promotes macrophage cytoskeleton remodelling and inhibits cell 
migration via down-regulating RhoA expression, which is mediated by reactive 
oxygen species (ROS) formation  
4.3.7.1 Co2+ and CoNPs induce ROS production U937 macrophages 
Heavy metal ions and nanoparticles can provoke cellular stress, which may lead to 
alterations in cellular structure and function, and potentially loss of cell viability. Both 
Co2+ and CoNPs induce ROS in a concentration-depended manner in U937 
macrophages, which occurs at non-cytotoxic concentrations (Figure 4.17A). The 
maximum increase in ROS production of approximately 90% compared to unstimulated 
cells, occurred within the first 30 minutes. This significant increase persisted for 4 hours 
of treatment but decreased after 6 hours. Exposure to CoNPs at 100-150 µM induced a 





75% at 150 µM (Figure 4.17B). Cobalt-treatment with ROS scavenger and antioxidant, 
NAC (N-acetyl-L-cysteine), abolished the cobalt-induced ROS production in cells 
(Figure 4.17A, B).  
        
 
Figure 4.17 ROS production induced by Co2+ and CoNPs. Values represent mean+SEM; 
n=12 replicates for control, 100µM, 200µM, 300µM Co2+ and 100µM, 50µM, 100µM 
CoNPs treatment from 4 independent experiments (3 replicates/experiment) and n=9 
for 300 µM Co2+ + 5mM NAC treatment and 150 µM CoNPs + 5mM NAC treatment 
from 2 independent experiments (2 replicates/experiment). (A: *** indicates significant 
upregulation for all of the three concentrations; B: **p < 0.01; ***p < 0.001; # indicates 
significant difference between cells treated with cobalt only and cells treated with both 





4.3.7.2 U937 macrophages cytoskeleton reorganization induced by cobalt was 
associated with ROS production.  
Further experiments were performed to determine whether ROS generation was 
responsible for the cobalt-induced podosome formation and the consequent inhibition 
of U937 macrophage migration. 200 µM Co2+-treated cells with NAC (5 mM) resulted 
in a significant reduction in the cobalt-induced podosome formation in individual cells 
as showed in Figure 4.18A and B.  
                  
Figure 4.18 Cobalt-induced ROS production stimulates podosome formation and 
impedes macrophage migration. (A) Fluorescence images showing that the ROS 
inhibitor, NAC (5 mM, 12 h) prevents Co2+ induced upregulation of podosome 
formation as shown by F-actin labelling with phalloidin and quantified in (B), n=150 







4.3.7.3 Inhibited U937 macrophages migration by cobalt was associated with ROS 
production.  
NAC treatment also induced a significant increase in macrophage transmigration 
exposed to cobalt (Figure 4.19). As mitochondria and NADPH oxidases are the main 
sources of cellular ROS, the effect of a NADPH oxidase inhibitor apocynin (5 μM, 10 
μM and 50 μM) was also tested. However, apocynin was not able to inhibit cobalt-
mediated ROS generation nor to restore macrophage migration (data not shown), which 
suggested that cobalt-mediated ROS increases are mainly mitochondria-derived. 
 
Figure 4.19 Macrophage migration inhibited by cobalt is rescued by treatment with 
NAC. Values represent mean + SEM. n=30 from 3 independent experiments; 10 
random fields were imaged for each treatment in each experiment. #p < 0.05, ##/**p 









4.3.7.4 Cobalt downregulates RhoA GTPase expression in U937 macrophages  
Actin organisation and podosome turnover are tightly regulated by the Rho GTPase, 
such as RhoA (Ras homolog gene family, member A), Rac1 (Ras-related C3 botulinum 
toxin substrate 1) and Cdc42 (Cell division control protein 42 homolog), whose activity 
is determined by their guanine nucleotide-bound state (Jomova and Valko, 2011). To 
determine if cobalt-induced ROS acts as an upstream regulator to activate Rho GTPases, 
the expression of RhoA, Cdc42 and Rac1 after U937 macrophages were treated by Co2+ 
(200 µM) and CoNPs (100 µM) was investigated. As shown in Figure 4.20A and B, 
cobalt did not affect the Rac1 and Cdc42 levels, but caused decreased RhoA expression 
indicating that Co2+ and CoNPs negatively regulate RhoA signalling. This was further 
confirmed by down-regulation of the downstream proteins of RhoA signalling, such as 
pMLC (phospho-myosin Light Chain) and pMYPT (phospho-myosin-binding subunit 
of myosin phosphatase).   
  
Figure 4.20 Cobalt do not affect the Rac1 and Cdc42 levels, but down-regulated RhoA 
expression. (A) Western blots results for untreated cell and cells treated with Co2+ and 
CoNPs. (B) The corresponding quantification demonstrating decreased RhoA 
expression. Values represent mean+SEM; n=12 replicates (4 replicates/experiment) for 
control, n=6 rerplicates (2 replicates/experiment) for Co2+ and CoNPs treatment from 3 





4.3.7.5 Inhibition of RhoA signalling promotes U937 macrophage cytoskeleton change 
and reduces macrophage migration  
In addition, the treatment of macrophages with the RhoA-specific inhibitor C3 
Transferase (2 μg/ml) and RhoA/ROCK1 pathway inhibitor Y-27632 (20 µM) also led 
to intensive cell spreading and increased podosome formation (Fig. 4.21A) as observed 
in cobalt-treated cells. Accordingly, the migration of U937 macrophages were also 
significantly impaired when RhoA signalling was inhibited by inhibitor C3 Transferase 
and Y-27632 (Figure. 4.21A, B).  
 
Figure 4.21 Inhibition of RhoA signalling promotes U937 macrophage cytoskeleton 
change and reduces macrophage migration. (A) Representative images showing the 
effects of inhibitor C3 Transferase and Y-27632 on U937 macrophage cytoskeleton 
organization and migration. (B) Quantification of the effects of C3 Transferase and Y-
27632 on U937 macrophage organization. Values represent mean + SEM. n=30 from 3 
independent experiments; 10 random fields were imaged for each treatment in each 







4.3.7.6 Inhibition of ROS generation by NAC partially restores RhoA activity.  
Furthermore, the reduced expression of RhoA level caused by Co2+ and CoNPs was 
significantly reversed by using the NAC (Figure. 4.22 A, B), which has showed to 
suppress the cobalt-induced ROS generation and be capable of partially restore the 
migration ability of U937 macrophages. These data suggest that cobalt-induced ROS 
production lies upstream of the RhoA signalling and down-regulation of RhoA 
expression results in remodelling of macrophage cytoskeleton and impaired migration.  
 
Figure 4.22 Inhibition of ROS generation via NAC restores RhoA activity. (A) Western 
blots results showing RhoA level reduced by Co2+ and CoNPs could be partially 
restored by inhibition of ROS with NAC (5 mM). (B) The corresponding quantification 
of cellular RhoA level with treatment by Co2+, CoNPs and NAC. Values represent 
mean+SEM; n=6 replicates (2 replicates/experiment) for each treatment from 3 













4. Discussion    
The mechanism of cell migration is controlled by a coordinated turnover of the actin 
and microtubule cytoskeletal network (Le Clainche and Carlier, 2008). Migration is 
regulated by actin polymerization with actin/myosin interactions forming contractile 
forces to retract the cell, while microtubules specify migration directionality (Ridley et 
al., 2003). When studying the effect of cobalt and chromium on these critical 
components of the cell migration machinery, it was observed a slightly decrease in the 
acetylation of α-tubulin in response to CrNPs occurred without affecting cell motility 
(Figure 4.5). In contrast, cobalt increased α-tubulin acetylation as well as inhibiting cell 
migration. To test whether increased acetylation initiates the inhibition of macrophage 
migration, cells were treated with Tubastatin A, a potent HDAC6 inhibitor. Tubastatin 
A treatment resulted in higher levels of α-tubulin acetylation than cobalt, and a 
reduction in macrophage migration, but to a smaller extend than cobalt (Figure. 4.6 and 
4.7). These results indicated that cobalt-induced tubulin acetylation was not the main 
cause of inhibited cell migration. 
Apart from tubulin modifications, it was found that cobalt induced alterations in 
macrophage morphology in the form of increased cell spreading as well as an increase 
in the number and density of podosomes (Figure. 4.8, 4.9 and 4.10). Both cell spreading 
and podosomes formation involve the deformation of a cell membrane and the 
strengthening of cell–substrate attachment (McGrath, 2007, Murphy and Courtneidge, 
2011). Podosome-type adhesions are rich in vinculin and other types of adhesion 
proteins, and regulate cell adhesion to the ECM (Murphy and Courtneidge, 2011). Cell 
spreading and short-lived podosome formations with their adhesion structures are 





Aepfelbacher, 2003). When either process is uncontrolled, cell migration can be 
hindered (Ilic et al., 1995). For example, the inflammatory mediator PGE2 has been 
shown to promote macrophage migration in response to chemotactic signals, but at high 
doses, it reduces macrophage chemotaxis by enhancing cell-substratum adhesion 
(Osma-Garcia et al., 2016). In the current study, it was confirmed that the non-toxic 
concentrations of Co2+ led to a concentration-dependent increase in cell adhesion to the 
ECM substrate (Figure. 4.12). These results suggest that the reduction in macrophage 
migration induced by cobalt is due to both the increased cell spreading and the enhanced 
podosome formation.  
The current study established that the molecular mechanisms through which cobalt 
regulates podosome adhesion and reduced migration, involves the formation of ROS 
(Figure. 4.17). Both Co2+ and CoNPs have been shown to promote generation of the 
oxidative stress and increase ROS levels in vitro (Kamiya et al., 2008). ROS is 
generated as a by-product during cellular oxidative metabolism, although its 
overproduction enhances cellular oxidative stress, transforming cells so they are unable 
to maintain normal physiological functions (Sauer et al., 2001, Bigarella et al., 2014). 
ROS are also the key signalling molecules during the progression of inflammatory 
disorders (Mittal et al., 2014), by modulating the production of inflammatory 
chemokines and expression of leukocyte adhesion receptors to accumulate circulating 
monocytes at affected sites (Mittal et al., 2014). Oxygen radicals produced by local 
macrophages may further facilitate macrophage accumulation and their activation, 
resulting in prolonged inflammation. The current findings indicate that the mechanism 
behind ROS role in the retention of infiltrated macrophages at the inflamed sites is 
through regulating the cytoskeleton reorganization, a finding that has not been 





The cytoskeleton reorganization in presence of ROS is driven by the ability of ROS to 
induce reversible oxidation of proteins, which involves direct modification of protein 
kinases and transcription factors (Meng et al., 2002). Major regulators of macrophage 
motility and cytoskeleton organization are influenced by Rho family GTPase (Jones et 
al., 1998, Konigs et al., 2014, Ridley, 2015), F-actin regulation pathways (Linder et al., 
1999) and tyrosine phosphorylation (Dwyer et al., 2016, Jones, 2000). The Rho family 
of GTPases play critical roles in cell motility by affecting actin organization and 
microtubule dynamics, myosin activity, and cell–ECM and cell–cell interactions 
(Hanna and El-Sibai, 2013). In this study, it was showed for the first time that cobalt-
induced ROS formation acts as an upstream regulator to directly inactivate the RhoA, 
leading to a reorganization of the macrophage cytoskeleton and impaired cell migration 
(Fig. 4.19, 4.20, 4.21 and 4.22). Small GTPase Rho is known to stimulate stress fiber 
formation and hamper the cell migration in many types of cells (Tojkander et al., 2012). 
It is even reported that inactivation of Rho in transformed fibroblasts by dominant 
negative RhoA or the C3 exoenzyme would disrupt podosome structure (Berdeaux et 
al., 2004), but also that podosome formation in Src-transformed fibroblasts could be 
promoted by limiting Rho activation (Schramp et al., 2008). In addition, it was recently 
revealed that podosome disassembly is associated with the activation of Rho and 
blockade of RhoA signalling, and could promote actin core assembly and podosome 
formation in macrophages (Rafiq et al., 2017).  
Underlying mechanisms through which biomaterials-induced ROS formation 
modulates macrophage behaviour are of considerable importance. Despite emerging 
advances in materials science, biomaterials do not behave like native biological 
components and frequently incite adverse tissue reactions, which may lead to ultimate 





evaluating the biocompatibility of biomaterials are of critical interest, especially 
understanding the cellular behaviour of macrophages because of their decisive role in 
the long term survival of implanted biomaterials in addition to orchestrating 





























Chapter 5. The effects of Co2+ and Cr3+ on ECM 
remodelling, fibroblast mechanical properties and 
fibroblast-macrophage interplay 
5.1 Introduction 
Local effects of CoCr metal ions in the periprosthetic tissue have been demonstrated to 
induce cytotoxicity, apoptosis, and necrosis with secretion of various cytokines and 
chemokines (Petit et al., 2004, Catelas et al., 2001, Fleury et al., 2006, Queally et al., 
2009). The released ions (Co2+ and Cr3+) that were reported to cause an issue in MoM 
implants, are now also frequently reported in patients with MoP bearings; the effects 
that have been increasingly reported include adverse local tissue reactions and 
pseudotumours (Plummer et al., 2016, Dimitriou et al., 2016, Kwon et al., 2016, 
Jennings et al., 2016). Histological evaluation of the synovial tissues from revision hips 
utilizing CoCr alloys frequently reveal  features with extensive tissue reaction, which 
is characterised by abundant tissue necrosis and fibrosis with infiltration of immune 
cells (Campbell et al., 2010). Although it is evident that the by-products generated in 
total joint replacements are associated with the aberrant tissue remodelling (Campbell 
et al., 2010, Willert et al., 2005), few studies have investigated how the cell processes 
are driven by cobalt and chromium.  
The extra cellular matrix (ECM) contains a diverse range of dynamic structures built 
from a complex web of secreted molecules. The ECM not only provides cells with 
structural support, but also regulates cellular function, cell fate and disease progression 
via chemical/mechanical cues and cell-matrix interactions (Iskratsch et al., 2014). For 
example, during chronic inflammation, aberrant ECM production and ECM protein 





activation and survival, thereby interfering with the resolution of inflammatory 
responses at these sites (Sorokin, 2010).  
Fibroblasts are the primary cell type responsible for collagen synthesis and the 
maintenance of collagen network tension (Eckes et al., 1999). Investigations into the 
biological response to metal debris and released ions have largely focused on whether 
certain types of cells would be able to survive when exposed to the material or how the 
profile of secreted cytokines are altered when immune cells are treated by cobalt and 
chromium (Madl et al., 2015b). However, how cobalt and chromium affect the 
functional properties of fibroblasts in terms of their cell-matrix interaction and ECM 
synthesis has not been fully elucidated. Tissues surrounding metal total hip implants 
obtained at revision operations are frequently characterised with massive infiltration of 
macrophages (Natu et al., 2012b); thus macrophages may also play an important role 
in mediating the fibrotic response of fibroblasts in the presence of cobalt and chromium. 
Therefore, the aim of this study was to investigate the effects of Co2+ and Cr3+ on human 
fibroblast-matrix interaction by utilising a 3D collagen culture systems to mimic the 
physiological ECM features. The effect of these ions on the fibrotic response of 












5.2.1 Preparation of Co2+ and Cr3+ ions solution   
Stock solutions (0.1 M) of Co2+ and Cr3+ ions were freshly prepared as described in 
section 3.2.1.       
5.2.2 Primary culture of human fibroblasts and U937 cells  
Human dermal fibroblasts (HDFs) 
Normal adult HDFs (PromoCell, UK) were grown in DMEM (4.5g/L glucose, Gibco, 
ThermoFisher Scientific) supplemented with 10% foetal calf serum (FCS, Sigma), 
0.625 μg/mL amphotericin B (Sigma), 100 IU/mL penicillin and 100 μg/mL 
streptomycin (Sigma). The medium was changed every 3 days until the cells reached 
80% confluency. HDFs between passages 3 and 8 were used for all experiments.  
U937 cell line 
U937 cell line (passage 6-25, donation from Dr. Akihisa Mitani, Imperial College 
London, UK) were cultured in RPMI 1640 medium as previously described in section 
3.2.3.  
Co-culture 
Porous plasma-treated polycarbonate inserts (pore size: 3 μm, Transwell, Corning, USA) 
were used for non-contact co-culture of fibroblasts. HDFs (0.4×105/well) were cultured 
at the bottom of the well (24-well tissue culture plate) and U937 macrophages (2×105) 





                    
Figure 5.1 Illustration showing the macrophages-fibroblasts co-culture system.  
3D culture 
Rat tail collagen type I (2mg/ml, Firstlink) was used to fabricate three-dimensional 
matrix by collagen fibril self-assembly. Solution (8:2) containing collagen (final 
collagen concentration: 1mg/ml) and 10X MEM (ThermoFisher Scientific) was 
adjusted to pH 7.4 using 1M NaOH, and by observing colour change from yellow to 
salmon pink. The required cell suspension was then added and the cell-containing 
collagen mixture was polymerised at 37 °C for 30 min in cell culture plates. Following 
this step, serum-free DMEM medium was added to the wells. For fibroblasts-containing 
gels, 2×105 cells/ml were used.  
5.2.3 Cell viability and proliferation test 
Cytotoxicity Assay 
A LIVE-DEAD® Cytotoxicity Assay Kit (ThermoFisher Scientific) was used to 
measure cell viability in the presence of Co2+ and Cr3+. HDFs in 96-well tissue culture 
plates at 5×103 cells/well for 2D and 2×104 cells/well for 3D, were exposed for 6h to 
200, 300 or 500 µM Co2+ or 200, 400, or 800 µM Cr3+. Following exposure, 
supernatants were removed and a 200 μL solution of 1 μM calcein AM and 2 μM 
ethidium homodimer in PBS was added to each well for 20 min. Fluorescence images 





were stained green with calcein AM (ex 495nm, em 530 ± 12.5 nm), while dead cells 
red with ethidium homodimer (ex 528nm, em 645 ± 20 nm). Three replicates of each 
condition were tested with the entire assay repeated in three separate experiments.  
Proliferation test 
HDF proliferation was measured using CellTiter 96® Aqueous One Solution Cell 
Proliferation Assay (MTS assay, Promega) according to the manufacturer’s instructions. 
HDFs in 96-well tissue culture plates at 5×103 cells/well for 2D and 2×104 cells/well 
for 3D studies. The cells were exposed for up to 96h to Co2+ or Cr3+ at concentrations of 
100 - 500 µM or 100 - 800 µM respectively. Following exposures, supernatants were 
aspirated and 100 μL of serum-free DMEM medium containing 10% CellTiter reagent 
was added to each well. Plates were incubated for 2h at 37°C and the absorbance was 
read at 490 nm using an Infinite F50 plate reader (Tecan). Five replicates of each 
exposure were tested and the entire assay was repeated in three separate experiments. 
The cell viability was determined as a percentage of control cell viability.  
5.2.4 3D Collagen Gel Assays 
Collagen gel contraction 
To measure collagen contraction by fibroblasts, 0.5 mL fibroblast-containing solution 
was added to 24-well cell culture plates and polymerized for 30 min at 37°C. Then 0.5 
mL of serum-free cell culture medium was added and the gels were incubated for 12h. 
Following the incubation, gels containing fibroblasts were gently detached from the 
wells using fine straight and curved forceps. The medium was aspirated and replaced 
with culture media containing Co2+ (100, 200 or 300 µM) or Cr3+ (100, 200 or 400 µM). 
The gel contraction was recorded by time-lapse imaging over 6h.  





Gel stiffness was evaluated for untreated samples or samples exposed to 200 µM Co2+ 
as described in the previous section. Shear rheology of fibroblast-containing gels was 
measured with a strain rotational rheometer (T.A. Instruments, UK). Storage modulus 
was measured over a strain range of 0.2 - 2% at a fixed angular frequency of 0.5 rad/s 
and a temperature of 21°C.   
5.2.5 Immunofluorescence   
Co2+ and Cr3+ -treated fibroblasts were fixed with 4% paraformaldehyde (Sigma, UK), 
washed and permeabilized with 0.5% Triton X-100 (Sigma, UK) then rinsed 3 times 
with PBS. Nonspecific binding sites were blocked with 1% BSA in PBS. Cells were 
labelled for α-Smooth Muscle Actin (α-SMA) by incubating the cells at 4°C overnight 
with a mouse monoclonal anti-α SMA primary antibody (1:400, Abcam, UK). Cells 
were then washed and incubated for 1h at room temperature in Alexa 488 conjugated 
anti-Mouse IgG as Secondary Antibody (1:1000, ThermoFisher, UK). To label the 
cellular F-actin, fixed fibroblasts in collagen gel were incubated for 30 min with 200 
μL of rhodamine-conjugated phalloidin (Molecular Probes, UK) in a humidified 
chamber at room temperature in the dark. Before imaging, cell nuclei were stained by 
incubation with 5 μg/mL DAPI (Dojindo, UK) followed by three PBS rinses. Slides 
were visualized with a fluorescence microscope (Leica SP2, Germany) utilising a x10 
and x63 objective.    
5.2.6 Fibroblast mechanical properties measurement   
Many studies have linked the changes in fibroblast mechanical properties, such as cell 
stiffness and cellular contractile force to its activation. Cell mechanical properties are 
closely associated with cell behaviour. A variety of approaches have been applied to 





cytoindentation and atomic force measurements (AFM) and traction force 
measurements (TFM). Here AFM and TFM were used to monitor changes in fibroblast 
mechanical properties.     
5.2.6.1 Atomic force microscopy 
Atomic force microscopy (AFM) is an invaluable tool to determine certain physical 
properties of specimens, especially their mechanical properties. Investigations of an 
sample is performed by using a fine tip attached to a cantilever to scan over the sample 
surface, The interplay between tip and sample causes the cantilever to bend while the 
bending of the cantilever can be detected by the deflection of a laser beam focused on 
the end of the cantilever. Then the force applied to the sample can be calculated via the 
cantilever bending, In addition, the bending of the cantilever is recorded as a function 
of its distance from the surface in the form of force-distance curves. As the tip 
approaches and retracts from the sample, the long-range attractive or repulsive forces 
between the tip and sample surfaces can be detected, which allows measurements of 
mechanical properties such as adhesion or elasticity on a nanometre scale.  
 
Figure 5.2 Principle of cell stiffness measurements (force-distance curves) performed 





The stiffness of human dermal fibroblasts was measured using Advanced Quantitative 
Imaging mode on a JPK NanoWizard 4 system in combination with an inverted 
microscope (Axio Observer Z1, Zeiss). Cantilevers (HYDRA6R, AppNano) were 
calibratedby first measuring the sensitivity against a stiff polystyrene substrate, and 
then fitting the resonance peak in the thermal noise spectrum to determine the spring 
constant (i.e. 0.07 ~ 0.08 N/m). A ROI of 100 µm × 100 µm was selected to cover an 
entire cell. Indentations were performed in a format of 32 × 32 at a loading/unloading 
speed of 50 µm/s, to minimize cell movement during scanning without compromising 
the resolution.  All the AFM experiments were carried out at 37°C in FBS-free medium 
with or without Co2+. Force-indentation curves were further processed in JPK data 
processing software, which was through background subtraction, height correction and 
fitting with a modified hertz model. The poisson’s ratio is assumed to be 0.5. Young’s 
modulus values ranging from 1kPa to 200 kPa were extracted and averaged to 
determine the overall stiffness of a cell.   
 
Figure 5.3 An optical image from the top-view camera integrated with the AFM 






 5.2.6.2 Traction force measurement 
Forces generated by cells are key regulators of cellular signalling and function. 
Contractile forces are generated by a cell via actomyosin contraction, which transmits 
to the ECM or neighbouring cells. It is very demanding to directly measure the cellular 
tractions as they are very small (piconewtons to nanonewtons) and occur across limited 
length scales (nanometers to micrometers). However, cell tractions can be determined 
through quantifying shape change or deformation of soft materials caused by the forces 
applied to it. Over the past two decades, many techniques have been developed to 
measure and map the forces generated by cells. 
 
 





As the most widely used technique for measuring cell force, cellular traction 
force microscopy (TFM) involves tracking the deformations of synthetic elastic 
polymer substrates induced by the exertion of cellular traction. Briefly, small 
fluorescent beads are integrated into deformable synthetic substrates, which can be 
tracked in time and space using optical microscopy. In general, it involves the following 
steps: 1) Imaging of the distribution of fluorescent beads in a stressed state; 2) Releasing 
cell tractions via cell lysis; 3) Imaging of the beads to record their positions in the 
unstressed state; 4) Computational algorithms are applied to analyse the two sequence 
images (before and after lysis) to determine the displacement of the beads, that the 
forces needed to induce such displacement exerted by the cells can be acquired.        
Detailed steps performed in the TFM experiment were as followed. Firstly, 22 mm 
coverslips (Corning) were first treated with Hexamethyldisilazane (HMDS, VWR) 
overnight, rinsed in distilled water, and air dried. A gel solution containing 5% 
acrylamide (Biorad), 0.25% bis-acrylamide (Biorad), ammonium persulfate (10% APS, 
Sigma), 1, 2-Bis (dimethylamino) ethane (TEMED, Sigma, USA) and carboxylate-
modified beads (fluorescent red, diameter 0.2 μm, 1% v/V, ThermoFisher) was added 
to the hydrophobic coverslips. After polymerization for 15 min at room temperature, 
the gel was activated with heterobifunctional cross-linker 1mg/ml Sulfo-SANPAH 
(Sigma) under UV light for 30 min and rinsed 5 times with distilled water. The coated 
coverslips were then conjugated with type I collagen (0.2 mg/ml). Fibroblasts, at a 
density of 3 × 104 cells/well, were plated on the coverslips in serum-free DMEM and 
subjected to Co2+ treatment (200 µM) for 6 hours prior to imaging (LS720 Microscope, 
Lumascope) in a humid incubator. Bright-field and 525 nm image stacks were acquired 
for each position. After imaging, fibroblasts were lysed with 1% SDS and the positions 





images were first aligned to correct the experimental shift in the z-position. Traction-
induced bead displacement and gel deformation were determined utilsing particle 
image velocitometry (PIV) using the iterative PIV plugin as described (Martiel et al., 
2015). A FTTC (Fourier transform traction cytometry) plugin was used to determine 
the traction forces and vectors. 
5.2.7 Transwell cell migration assay 
Cell migration was investigated using 6.5 mm Transwell chambers with 8 μm pores 
(Costar, Corning, NY, USA). Briefly, 5×104 harvested fibroblasts in serum free DMEM 
medium were added to the upper chamber of the insert. The lower chamber was filled 
with 600 µl DMEM medium with 10% FBS to encourage cell migration down the FBS 
chemotactic gradient. Cell migration was analysed over a 6-hour period in the presence 
of 200 µM Co2+. After 6 hours treatment, cells remaining on the membrane were fixed, 
stained with crystal violet and counted. 
5.2.8 Reactive oxygen species measurement 
ROS formation was measured using CM-H2DCFDA (ThermoFisher). HDFs in collagen 
gels (2×104 cells/gel) were cultured in black 96-well cell culture plates with a clear 
bottom. Following up to 6h exposure to 100-300 µM Co2+, the supernatant was 
aspirated and cells were washed with warmed PBS. 1μM (100 µl) CM-H2DCFDA in 
HBBS was added to the gels and they were incubated for 30 min at 37°C in the dark. 
Fluorescence was read at excitation 485/20 nm with emission 528/20 nm using a 







5.2.9 Hydroxyproline content measurement  
To measure the amount of hydroxyproline released in the cell culture medium, HDFs 
were exposed to 200 μM Co2+ or 400 μM Cr3+ with or without U937 macrophages 
presence for 24h. The culture medium was collected and hydrolyzed in 6N HCl for 24h 
at 105 °C. The amount of 4-hydroxy proline in the hydrolyzate was determined at the 
wavelength of 570 nm using a microplate reader (BMG Nova Star, BMG LABTECH) 
using the conventional colorimetric method (Reddy and Enwemeka, 1996). 
5.2.10 Protein extraction and Immunoblotting  
Protein extraction and immunoblotting were performed as described in section 4.2.2. 
Anti-myosin light chain (phospho S20) antibody (1:1000, Abcam) and anti-GAPDH 
antibody (1:2000, Abcam) were used.  
5.2.11 Data analysis and statistics 
Normality testing (Kolmogorov-Smirnov test) was performed for all experimental data. 
All data are expressed as the median or mean ± SEM from independent repeat 
experiments (N=3). The number of repeat measurement per experiment (n) is indicated 
for each figure. Statistics analysis conducted with SPSS (Inc., Chicago, IL, USA) for each 











Experiments  Statistics methods 
Cell viability assay  one-way ANOVA with Bonferroni post-hoc t-test 
Cell proliferation assay  one-way ANOVA with Bonferroni post-hoc t-test 
Cell length measurement  one-way ANOVA with Bonferroni post-hoc t-test 
Collagen gel contraction 
measurement  
one-way ANOVA with Bonferroni post-hoc t-test 
Collagen gel stiffness 
comparison   
paired Student’s t-test (two- tailed).       
Transmigration assays unpaired Student’s t test 
Cell elastic modulus 
comparison   
unpaired Student’s t test 
Cell fibroblast contractile 
force 
unpaired Student’s t test 
Protein expression analysis 
via western blot 
one-way ANOVA with Bonferroni post-hoc t-test 
ROS production analysis one-way ANOVA with Bonferroni post-hoc t-test 
Hydroxyproline measurement  one-way ANOVA with Bonferroni post-hoc t-test 
α-SMA positive fibroblasts 
analysis  














5.3 Results  
5.3.1 Human Dermal Fibroblast viability following exposure to Co2+ and Cr3+ 
A live/dead assay was first applied to assess the acute effects of Co2+ and Cr3+ on the 
viability of fibroblasts. Figure 5.5A shows images of fibroblasts in 2D tissue culture 
plates and 3D type I collagen matrix from the live/dead fluorescence assay taken at 20× 
magnification. Quantitatively, Co2+ (200, 300 and 500 µM, Figure 5.5B) and Cr3+ (200, 
400, 800 µM, Figure 5.5C) showed little or no evidence of toxicity on fibroblasts in 2D 
and 3D matrices following 6 hours of exposure.    
 
Figure 5.5 Images of human fibroblasts in the Live/Dead cell assay taken under 20× 
magnification. A. fluorescent staining of live and dead cells exposed to Co2+  and Cr3+, 
B. Quantification of cell viability when treated by Co2+ (200, 300 and 500 µM); C. 
Quantification of cell viability when treated by Cr3+ (200, 400, 800 µM). Data 





5.3.2 Fibroblast proliferation during exposure to Co2+ and Cr3+ 
The effect of Co2+ and Cr3+ on the proliferative capacity of fibroblasts was also 
investigated by using an MTS assay. When cultured on TCP, Co2+ had no obvious 
effects on fibroblast proliferation over the first 24 hrs of treatment (Figure 5.6A). After 
48 hrs of exposure, Co2+ from 100, 200 and 300 µM transiently increased the number 
of fibroblasts by around 5, 5 and 8% respectively before returning to control levels, 
while the increase was not statistically different. In addition, Co2+ at 500 µM 
significantly decreased the fibroblast proliferation by around 20% compared with 
untreated cells at day 2 and 3. Similarly, Co2+ also supressed cell proliferation in 3D 
collagen matrices after 72 hours. On the other hand, Cr3+ ranging from 200-800 µM 
had no statistically significant effect on fibroblast proliferation ability over 3 days of 
treatment (Figure 5.6B).   
 
Figure 5.6 Effects of Co2+ (A) and Cr3+ (B) on HDFs proliferation capacity when grown 
in 2D tissue culture plates and 3D type I collagen matrix. Data represents mean +SEM, 






5.3.3 Morphology of fibroblasts when cultured in type I collagen matrices when 
exposed to Co2+ and Cr3+ 
The direct impact of Co2+ on fibroblast activation and function still remains poorly 
understood. To investigate this, fibroblasts in type I collagen matrices were incubated 
and their cell morphology was evaluated. As shown in Fig 5.7A, Co2+ treatment induced 
a contracted morphology and the reduced fibroblast’s length, while untreated cells and 
Cr3+-treated cells remained with an elongated spindle-like appearance in the collagen 
matrices. An increased formation of actin stress fibres was also observed in Co2+-treated 
cells. 
 
Figure 5.7 Co2+ induces fibroblasts morphology change in collagen gel. (A) F-actin 
staining of human fibroblasts grown in 3D collagen I. Right: Bars show quantification 
of the longest distance of fibroblast grown in 3D collagen I. Bars represent mean + 
SEM; n = 50 individual cells from three experimental repeats. Statistically significant 







5.3.4 Remodelling of HDF-seeded collagen gels following exposure to Co2+ 
5.3.4.1 Contraction of HDF-seeded collagen gels following exposure to Co2+ 
The effect of cobalt on the fibroblasts ability to contract and remodel their surrounding 
matrix was subsequently investigated. Over 6h exposure, Co2+ enhanced collagen gel 
contraction by fibroblasts in a time-dependent manner whilst untreated cells showed 
negligible contraction (Figure 5.8A, B). The collagen gels were contracted by nearly 
50% within the first hour following exposure to Co2+ (100-300 µM). The higher dose 
of Co2+ (300 µM) triggered a faster contraction of the collagen matrices with significant 
differences at 30 min compared to 100 µM Co2+. By contrast, Cr3+ treatment from 100-
400 µM showed no statistically significant effect on collagen gel contraction (Figure 
5.8 – data only shown for 400 µM Cr3+).  
  
Figure 5.8 Co2+ triggers fibroblasts-populated collagen gel contraction. (A) HDFs-
induced gel contraction assay. Images show HDFs-induced contraction of collagen I 
matrices remodelling over 6 h of treatment; (B) quantification of Co2+/Cr3+-induced 
collagen gel contraction relative to control; bars indicate mean ± SEM; n=6 from three 
experimental repeats. Statistically significant difference is indicated relative to 







5.3.4.2 Stiffening of HDF-seeded collagen gels following exposure to Co2+ 
Shear rheology indicated that storage modulus of the cell seeded collagen gels was 
independent of strain (Figure 5.9A). Cells treated with Co2+ remodelled their collagen 
matrix resulting in a statistically significant increase in storage modulus from a mean 
value of 6.9 ± 0.74 Pa in untreated constructs to 12.5 ± 1.3 Pa following 6h treatment 
with 200 µM Co2+ (Figure 5.9B). In addition, Cr3+ had no significant effect on 
fibroblasts-populated collagen gel (data not showed). 
 
Figure 5.9 Stiffening of collagen gels following treatment of Co2+. (A) Left: Matrix 
stiffness of collagen gel with or without 200 µM Co2+ treatment. The storage modulus 
(G’) of collagen I was measured by shear rheology after 6h of fibroblasts remodelling; 
Scatter plot indicates storage modules from 3 matched testing. (B) Comparison of 
collagen gel stiffness before and after treating by Co2+. Bars indicate mean ± SEM; n=6 
from three experimental repeats. Statistically significant difference is indicated relative 









5.3.6 HDF-seeded collagen gels remodelling treated by Co2+ is not caused by 
enhanced cell migration  
The effect of Co2+ on cell migration was examined as previous studies suggested that 
collagen gel contraction may be due to an enhanced cell motility (Andujar et al., 1992). 
However, no significant effect of Co2+ (200 µM) on fibroblast 3D migration when using 
a transwell migration assay (Fig. 5.10A and B) was observed.  
 
Figure 5.10 The effect of Co2+ on fibroblast migratory ability. (A) Representative 
images of migrated cells stained after migration assays for untreated cells and Co2+-
treated cells. (B) Results of the migration assays for the two group. Quantifications of 
the migration assay based on three independent experiments. Values represent 
mean + SEM. n=30 from three independent experiments; for each experiment, 10 










5.3.7 Co2+-induced fibroblast contractility is associated with altered biomechanical 
properties  
5.3.7.1 Co2+ affects fibroblast elastic modulus  
Firstly, the cell stiffness was assessed by using atomic force microscopy. According to 
the AFM images and analysis (Fig. 5.11A, B), the stiffest part of the fibroblast 
corresponds to the periphery of the cell, which indicates the higher density, cross-link 
content and better alignment of the actin at the edge of the cell. Compared with 
untreated cells, Co2+-treated fibroblasts showed increased stiffness, which was 
characterised by the statistically significant differences in elastic moduli compared to 







Figure 5.11 Altered cell stiffness of fibroblasts due to Co2+ treatment. (A) 
Representative images showing the Young’s modulus of the control and of Co-treated 
fibroblasts and associated density plot (B) showing distribution of the measured 
stiffness for values of individual locations of measurement within the physiological 
range of 0 kPa to 100 kPa,. (C): Quantification of mean cell stiffness of control and of 











5.3.7.2 Co2+ treatment increases fibroblast contractile force 
Fibroblasts exposed to Co2+ exhibited a nearly 80% increase in cellular contractile force 
(p < 0.01, Figure 5.12A and B). Traction forces in Co2+-treated cells were found to be 
higher at the edge of a cell as well as underneath the cell body. Collectively, the increase 
in the Young's modulus and cellular contractile force of Co-treated cells correlated with 
the alterations in their morphological and ECM-modulating capability.  
 
 
Figure 5.12 Contractile forces of a representative control and Co2+-treated fibroblast. 
(A) Bright field images of individual cell (i) and corresponding stress magnitude maps 
(ii). Scale bar indicates 50 µm. (B): Quantification cellular contractile force of 
fibroblasts from control and untreated cells; n=30 from three independent experiments; 









5.3.7 Co2+ promotes phosphorylation of myosin light chain (MLC) and ROS 
production. 
5.3.7.1 Co2+ promotes phosphorylation of myosin light chain (MLC)  
Cellular contractile state is governed by the actin-myosin-mediated motor activity 
(Ennomani et al., 2016). Non-muscle myosins are regulated by the cyclic 
phosphorylation and activation of myosin light chain (MLC) (Vicente-Manzanares et 
al., 2009, Moussavi et al., 1993).  In the present study, Co2+ (200 µM) induced a 
sustained enhancement in phosphorylation of MLC over 6 hours of treatment. The 
increase of approximately 80% occurred within 10 min following the initiation of Co2+ 
treatment (Fig 5.13A). 
 
Figure 5.13 Co2+ induced phosphorylation of myosin light chain (MLC). (A) 
Phosphorylation of MLC stimulated by 200 µM Co2+over 6 hours of treatment. (B) 
Quantification of the phosphorylation of myosin light chain (MLC) stimulated by 200 
µM Co2+ over time. Values represent mean + SEM; ** p < 0.01; n=6 from three 








5.3.7.2 Co2+-induced phosphorylation of MLC requires ROCK activity and depends on 
ROS formation  
Phosphorylation of myosin is known to be catalyzed either by Myosin Light Chain 
Kinase (MLCK) or by Rho-associated coiled-coil–forming kinase (ROCK) (Fukata et 
al., 2001). By applying the MLCK inhibitor ML-7 (10 µM, Sigma) and ROCK1 
inhibitor Y-27632 (10 µM, Sigma), we found that ML-7 did not have an inhibitory 
effect, while Y-27632 pre-treatment completely prevented the collagen gel contraction 
by fibroblasts. ROCK1 is activated by small GTPase RhoA (Tang et al., 2012), 
therefore the activity of RhoA was inhibited by treating fibroblast during cobalt 
exposure with the cell permeable RhoA inhibitor, C3 transferase (2 µg/ml, 
Cytoskeleton). However, supressing RhoA activity did not prevent the collagen gel 
contraction (Figure 5.14A). Hence, cobalt did not induce fibroblast contraction via the 
RhoA/ROCK1 signalling pathway although ROCK activity is required during this 
process.  
It has been reported previously that exposure to Co2+ induced reactive oxygen species 
(ROS) formation (Chandel et al., 1998, Zou et al., 2001, Harris and Shi, 2003). When 
cells were treated with a ROS inhibitor in the form of the antioxidant, NAC (5mM, 
Sigma), Co2+ -induced fibroblast contractility was completely prevented (Figure 5.14B). 
Further, treatment with NAC reduced the phosphorylation of MLC to base levels 
similar to that in untreated cells (Figure 5.14C and D). In summary, these results suggest 
that Co2+ induces activation of the fibroblast contractile phenotype by promoting MLC 







Figure 5.14 Co2+-induced fibroblast activation is dependent on ROS production. (A) 
The effects of antioxidant NAC, ROCK1 inhibitor Y-27632, MLCK inhibitor ML-7 
and RhoA inhibitor C3 transferase on cobalt-mediated collagen gel contraction by 
fibroblast. Values represent mean + SEM; *** indicate difference from cell only treated 
by Co2+, n= 6 from 3 independent experiments (2 replicates/experiment); *** P < 0.01; 
(B) ROS formation stimulated by 100 - 300 µM Co2+over 6 hours of treatment and 
inhibition of ROS formation by NAC. Values represent mean + SEM; n= 9 from 3 
independent experiments (3 replicates/experiment); *** indicate difference from 
untreated cells, P < 0.001. (C) The effects of antioxidant NAC and ROCK1 inhibitor 
Y-27632 on the phosphorylation of MLC. (D) Quantification of the phosphorylation of 
MLC when NAC was added; n= 6 from 3 independent experiments (2 













5.3.7 Co2+ stimulates the release of pro-fibrotic signals from macrophages  
To investigate whether Co2+ -induced fibroblast contraction is accompanied with 
enhanced collagen production, the amount of hydroxyproline secreted by the fibroblasts 
following different treatments (Myllyharju and Kivirikko, 2004) was measured. As 
shown in Figure 5.15A, Co2+ or Cr3+ alone did not have any obvious effect on pro-
collagen production. However, when U937 macrophages were exposed to Co2+ or Cr3+ 
the amount of hydroxyproline content in the culture medium was significantly 
increased. Interestingly, for co-cultures of fibroblasts and macrophages, treatment with 
Co2+ induced a synergistic response with an increase in hydroxyproline release of 
nearly 5 times that seen in macrophages alone (Figure 5.15A). Co-cultures treated with 
Cr3+ did not exhibit this synergistic effect. 
The degree of α-SMA expression, a marker of contractile and collagen-producing 
fibroblasts (Hinz, 2010), was also determined to assess the activation of cells exposed 
to cobalt and chromium. The number of α-SMA positive fibroblasts were significantly 
upregulated when macrophages and fibroblasts were co-cultured in the presence of Co2+, 
as quantified in Figure 5.14B and shown in Figure 14C. These results indicate that Co2+ 
stimulated the release of pro-fibrotic signals from macrophages, which enhance the 






Figure 5.15 Co2+ stimulated the release of pro-fibrotic signals from macrophages. (A) 
Fold of change in the amount of hydroxyproline content measured in the culture 
medium from fibroblast when treated by Co2+ (200 µM), Cr3+(400 µM) with or without 
U937 macrophages or co-culture without treatments. Values represent mean + SEM; 
n= 9 from 3 independent experiments (3 replicates/experiment). (B) Fold of change in 
the percentages of α-SMA positive fibroblasts with different treatments as described in 
(A). n=30 from 3 independent experiments; 10 random fields were imaged for each 
treatment in each experiment. (C) Representative Images of fibroblasts with α-SMA 
marker stained in each group; green: α-SMA; blue: nucleus; scale bar indicates 200 µm. 











Clinical reports highlight the presence of a soft tissue response and soft tissue 
destruction in patients with MoM implants showing abundant tissue necrosis, fibrosis 
and an inflammatory response (Campbell et al., 2010). How the metal debris, whether 
in particulate or ionic form, causes the destruction of soft tissue remains unclear. To 
elucidate this mechanism we investigated the effect of cobalt and chromium on human 
fibroblasts, the key cells involved in ECM remodelling.  
The results showed that Co2+ but not Cr3+ significantly enhanced the capability of HDFs 
to contract extracellular matrix (ECM), in our case collagen type I gels. The enhanced 
contractility was associated with an alteration in the cytoskeleton and biomechanical 
properties. Furthermore, Co2+ stimulated the release of pro-fibrotic signals from 
macrophages, which subsequently promoted the collagen synthesis and increase in α-
SMA positive fibroblasts.  
In our study we used both 2D and 3D models to study the effect of Co2+ or Cr3+ at non-
cytotoxic concentrations on human fibroblasts. We observed increased contraction of 
fibroblast-populated collagen gels after treatment with Co2+. This response associated 
with changes in fibroblast cytoskeleton, which gradually led to a stiffer collagen 
matrices. Using atomic force microscopy and traction force microscopy, we found that 
altered fibroblast contractility was associated with changes in the mechanical properties. 
Cobalt exposure caused a significant increase in cell stiffness and enhanced contractile 
forces. This is in line with previous observations that the biomechanical properties of 
fibroblasts serve as a key regulator of the cell’s ability to organize the ECM (Rhee, 





able to dynamically shape the ECM due to alteration their cytoskeleton, in result 
mediating the progression of tumor growth (Alkasalias et al., 2017).  
It was found that Co2+ drives the contraction of fibroblasts by regulating MLC 
phosphorylation, which could be abrogated by ROS scavenger. Co2+ is known to lead 
to the generation of reactive oxygen species (ROS) in a range of cell types (Leonard et 
al., 1998). Our results indicate for the first time that this cobalt-induced ROS formation 
also plays a critical role in ECM modulation by fibroblasts.  
Following fibroblasts’ activation they differentiate into myofibroblasts (MFs), this is 
widely observed in conditions requiring tissue remodelling, such as wound healing and 
fibrosis. MFs form contractile stress fibers and express de novo α-smooth muscle actin 
(α -SMA) (Tomasek et al., 2002). In the current work cobalt exposure led to the 
differentiation of HDFs by enhancing α -SMA expression, however this was only 
observed during co-culture with macrophages. Also only during fibroblast-macrophage 
co-culture, cobalt promoted the release of collagen (in the form of hydroxyproline) from 
fibroblasts. Macrophage plays a critical role in disease progression and in mediating 
the interplay between tissue and biomaterials. Previous studies showed that immune 
cells are affected by the matrix stiffness, e.g. stiffer substrates enhanced neutrophil 
transmigration (Stroka and Aranda-Espinoza, 2011) and release of pro-inflammatory 
cytokines by macrophages stimulated with LPS (Blakney et al., 2012). These findings 
indicate that immune cells probe and sense the alteration in the mechanical properties 
of the extracellular environment, hence could interact with the altered matrices by 
contractile fibroblasts. This could explain the enhanced pro-fibrotic response of cobalt-





Macrophages are capable of not only directly activating fibroblasts by releasing TGFβ1 
(transforming growth factor-β1) and PDGF (platelet-derived growth factor) (Bonner et 
al., 1991, Wahl et al., 1990), but also control ECM turnover by regulating the balance 
of matrix metalloproteinases and their inhibitors (Fallowfield et al., 2007, Madala et al., 
2010, Hironaka et al., 2000). Moreover, macrophages exacerbate fibrogenesis by 
producing chemokines that recruit fibroblasts and other inflammatory cells (Wynn, 
2007). Furthermore, cobalt-treated macrophage also promote the cellular α-SMA 
expression, which is associated with upregulated collagen synthesis ability of 
fibroblasts compared with α-SMA (-) fibroblasts. Moreover, cobalt stimulates 
macrophages to release a range of inflammatory mediators, such as IL-1β and TNF-α 
(Goodman, 2007), which can also affect ECM turnover and tissue homeostasis. In 
summary, there is a link between cobalt-induced fibroblast activation, ROS production 
and the enhanced response in the presence of macrophages. 
Total joint replacements may trigger unusual tissue remodelling (Campbell et al., 2010, 
Willert et al., 2005), activated by the release of metal, and in particular Co2+. 
Understanding these mechanisms through the study of fibroblasts and the co-culture 
with macrophages has provided an indication that the control of ROS could influence 











Chapter 6. Investigation of the synovial fibroblasts and 
tissues and from patients with CoCr metal-on-metal 
hip implants and primary THA patients     
6.1 Introduction 
Tissue changes are often observed following the use of cobalt chromium implants. Soft 
tissue reactions including pseudotumour, ALVAL and metallosis (usually defined as 
aseptic fibrosis and local necrosis) are believed to be the sequelae of large amounts of 
metal debris released from MoM hip bearings due to wear and corrosion. The spectrum 
of these tissue reactions is extensive and ranges from small asymptomatic cysts to 
formation of destructive periprosthetic soft-tissue masses (Campbell et al., 2010). 
Histological methods have been used to observe and investigate the synovial lining 
integrity, inflammatory cell (lymphocytes, macrophages, plasma cells and giant cells) 
infiltrates to examine the degree of ALVAL (Willert et al., 2005). Also, numerous 
studies have documented the role of immune cells in the initiation and progression of 
the tissue reactions (Matharu et al., 2016, Pandit et al., 2008). However, few studies 
have examined the alteration of fibroblasts and tissue/ECM organization when 
subjected to wear and corrosion products in vivo. Fibroblasts have been reported as cells 
supplying ECM proteins such as collagen and fibronectin (Tracy et al., 2016). However, 
in addition to this essential function, they also play an important role in modulating 
inflammation progress. It has been suggested that some of the chronic inflammation 
occurs because of the activated fibroblasts, which result in the inappropriate survival 





In the chapter 5 it was shown that Co2+ ions promote fibroblasts contraction and 
stimulate the release of pro-fibrotic signals from macrophages thus leading to the 
fibrotic reactions and matrix remodelling. In order to verify these events in vivo, the 
synovial fibroblasts and periprosthetic synovial tissues from patients with metal-on-
metal hip implants at their revision operation and patients undergoing a primary hip 
replacement operation were analysed to elucidate cellular and histological changes.  
6.2 Method 
6.2.1 Tissue collection 
6.2.1.1 Ethical approval and patient selection    
Ethical approval was obtained from the West London Research Ethics Committee 3 
[07/Q0401/25]. Signed and written consent for the use of tissue samples (synovial 
membranes) removed during surgery was obtained from the patients. Soft tissue 
samples were collected from patients undergoing either a primary hip replacement 
surgery (control) or a revision surgery of MoM hip implant during surgery performed 
by Prof. Alister Hart at the Royal National Orthopaedic Hospital and the London Clinic. 
All tissue specimens were anonymised. 
6.2.1.2 Inclusion and exclusion criteria 
All patients with unilateral or bilateral total hip replacement were included in this study. 
Patients with prostheses made of components other than MoM, such as metal-on-
polyethylene and metal-on-ceramic, were excluded from this study. The selection 
criteria for failed MoM were: unexplained pain, implant loosening and high cobalt and 
chromium levels in the blood (Table 6.1). The exclusion criteria were infection, 





Table 6.1 Patient demographics. 








1 F 53 / 
2 F 53 / 
3 F 54 / 
4 F 53 / 
5 M 49 / 
6 F 58 / 
7 F 62 / 




1 F 28 3 
2 F 59 15 
3 F 83 10 
4 F 64 5 
5 M 61 14 
6 F 88 7 
7 F 49 1 
8 M 73 6 
 
6.2.1.3 Tissue harvest and storage 
Tissues were collected from patient’s synovial membrane enclosing the 
acetabulofemoral joint cavity, where the hip prostheses were implanted. Tissues from 
the control group were obtained from patients undergoing primary total hip replacement. 
Tissues harvested from patients were immediately collected, processed and stored 
appropriately in -80 °C. For histology, tissues were fixed in 10% Neutral Buffered 
Formalin (Sigma, UK) at room temperature before processing. 
6.2.2 Isolation and Culture of synovial Fibroblasts 
Primary fibroblasts were isolated immediately from biopsies obtained from the patients. 
First, harvested tissues were transferred into a 10 cm tissue culture dish in DMEM 
medium using a sterile forceps and finely minced into approximately 1 mm3pieces 
using sterile scalpels. Then the pieces of tissues were placed in a 15 mL centrifuge tube 





UK) and incubated at 37°C in a horizontal orientation for 2 hours. 15 mL DMEM 
medium was subsequently added to dilute the collagenase which was passed through a 
70 m cell strainer (BD) to obtain a single-cell suspension. The cell suspension was 
centrifuged for 5 min at 200 x g at room temperature, the supernatant was discarded 
and the pellet resuspended in 1 mL DMEM medium. Harvested cells were counted and 
seeded at approximately 4,000 cells/cm2 in a T75 flask. The human synovial fibroblasts 
were cultured at 37°C and 5% CO2, with a first medium change 24-48 hours later. The 
medium was changed every 2-3 days.   
6.2.3 Cell metabolic activity measurement 
Synovial fibroblast proliferation was measured using CellTiter 96® Aqueous One 
Solution Cell Proliferation Assay (Promega) according to the manufacturer’s 
instructions as described in section 5.2.3. 
6.2.4 Collagen contraction 
Fibroblast-mediated matrix contraction was assessed using collagen gel lattices, as 
described in section 5.2.4. Moreover, to determine fibroblast response to cytokines and 
growth factors, gels were made using serum free (SF) medium with the addition of one 
of the following factors: IL-1β (10 ng/ml, Peprotech, UK), PDGF-BB (10 ng/ml, 
Peprotech, UK) or TGF-β 1 (5 ng/ml, Peprotech, UK). 
6.2.5. Fibroblast mechanical properties measurement   
Fibroblast contractile force and stiffness was measured as described in section 5.2.6. 
6.2.6 Collagen production measurements  
The amount of hydroxyproline released in the cell culture medium was measured as 





6.2.7 Immunohistochemical staining   
6.2.7.1 Tissue embedding and cutting   
Tissues, fixed in 10% neutral buffer formalin, were processed using the Histology 
department facilities at the Blizard Institute Core Pathology, Queen Mary School of 
Medicine and Dentistry. Briefly, fixed tissues were dehydrated through a series of 
graded ethanol baths (70%, 90%, absolute ethanol) to displace the water, cleared in 
xylene (Sigma, UK) bath and finally embedded in paraffin and placed on ice at -20°C 
overnight. After incubation tissue in the wax blocks were trimmed and placed again 
overnight. Finally, wax blocks were cut on an Accu-Cut® SRMTM 200 rotary 
microtome (Torrance, CA, USA) into 5 μm sections. Sections were placed into a hot 
water bath (40°C) to smooth the sections and were removed using glass microscope 
slides. Sections were left to drain and placed in an oven to soften the paraffin wax 
(60°C). 
6.2.7.2 Sample staining 
Slides were first deparaffinized by washing in 2 changes of xylene and graded ethanol 
baths (absolute ethanol, 90%, 70%). Antigen retrieval was performed to unmask the 
antigenic epitope of the tissue sample by boiling the deparaffinized sections in citrate 
buffer at pH 6.0. Endogenous peroxidase activity was locked by incubating sections in 
3% H2O2 solution (Sigma, UK) in PBS at room temperature for 10 min followed by 2 
rinses in PBS. To reduce background staining and any other immunostaining 
application, the samples were incubated with normal goat serum (5% in PBS) to block 
nonspecific binding sites in a humidified chamber at room temperature for 1 hour before 
staining. After draining the blocking buffer, 100µl of diluted primary antibody (in 1% 





humidified chamber at room temperature for 1 hour, after which the slides were washed 
twice in PBS. Then 100 µl of diluted biotinylated secondary antibody (in 1% goat serum 
in PBS) was applied to the sections on the slides and incubated in a humidified chamber 
at room temperature for 30 min with the slides washed in PBS after that. Amplification 
of antigen was achieved using an Elite® ABC-HRP Kit (Vector Laboratories, UK) and 
positive staining was visualized by using a DAB Peroxidase (HRP) Substrate Kit 
(Vector laboratories, UK).  
6.2.8 Image analysis 
Images were acquired on a Nikon Eclipse upright microscope. For image quantification, 
the mean percentage area positive for 10× randomly selected high powered fields (×10 
magnification) was calculated using ImageJ analysis software as described (Jensen, 
2013). 
6.2.9 Data analysis and statistics 
Statistical analysis was conducted with SPSS (Inc., Chicago, IL, USA) for each assays are 
listed in Table 6.2.  
Table 6.2 Statistics methods for each assays. 
Experiments  Statistics methods 
Cell proliferation assay  unpaired Student’s t test 
Collagen gel contraction measurement  Mann–Whitney U test 
Cell fibroblast contractile force unpaired Student’s t test 
Cell elastic modulus comparison   unpaired Student’s t test 
Hydroxyproline measurement  unpaired Student’s t test 
Collagen deposition comparison   unpaired Student’s t test 
α-smooth muscle actin expression cells 
analysis   





6.3 Results  
6.3.1 Synovial fibroblast proliferation  
The proliferative capacity of human synovial fibroblasts from patients in the control 
group (primary THA) and patients with a MoM implant (MoM) were investigated with 
an MTS assay. Proliferation of fibroblasts from MoM patients was not significantly 
different to cells cultured from primary THA patients over 72 hours (Figure 6.1). 
 
Figure 6.1 Synovial fibroblasts proliferation capacity over 3 days of culture. Bars 
represent mean + SEM; n = 72 from three independent experiment; 3 replicates/cell for 









6.3.2 Fibroblasts from patients with metal-on-metal implant exhibit a higher 
ability to contract 3D collagen matrices  
An in vitro collagen gel contraction assay was applied to determine the contractile 
profile of fibroblasts from MoM and primary THA, in the presence of serum (10%) or 
cytokines and growth factors. When cultured in serum-free medium without any 
stimulating factors, fibroblasts from the two groups showed similar ability to contract 
the collagen gel (Figure 6.2).  Fibroblasts from MoM patients were generally more 
contractile than fibroblasts from primary THA patients in most conditions, this trend 
was significant for serum (p < 0.05), PDGF (p < 0.01) and TGF-β (p < 0.01) stimulation 
(Figure 6.2 B-D). Fibroblasts from both groups responded well to TGF1 and PDGF, 
but the response to IL-1 was limited (Figure 6.2E). When stimulated by PDGF and 
TGF1 1, fibroblasts from MoM patients induced 56.9 ± 3.8% and 59.5 ± 3.7% 
contraction of the collagen matrices after 48 hours of treatment respectively, while 
fibroblasts from primary THA patients merely showed 31.7 ± 3.1% and 40.3 ± 2.9% 






Figure 6.2 Synovial fibroblasts from patients with MoM implant display increased 
matrix contraction abilities. Fibroblasts from MoM and primary THA were embedded 
in collagen matrix and contraction was measured after 48 hrs, in serum-free medium 
(A), medium with 10% serum (B), or with cytokines (PDGF 10 μg/mL, TGF-1 5 
μg/mL and IL-1 10 ng/mL). (A-E) fibroblasts from MoM patients exhibited higher 
contraction compared to fibroblasts from primary THA patients in the presence of 
serum (* p = 0.0108, two-tailed t-test), PDGF-BB (** p = 0.0023), TGF-1 (** p = 
0.0053). Shown is mean ± SEM for gel contraction after 48 hrs of culture. n = 6 from 
three independent experiment; 2 replicates/patient for each experiment from MoM (8) 







6.3.3 Fibroblasts from patients with metal-on-metal implant display altered 
contraction force   
It was shown in chapter 5 that there was a relationship between fibroblast’s contraction 
potential and their mechanical properties. To determine whether the higher capacity of 
fibroblasts from MoM patients to contract collagen matrices was also associated with 
upregulated intrinsic cellular force level, the cellular contractile force of both groups at 
resting state (after 24 hours starvation in serum-free medium) was measured. According 
to the results showed in Figure 6.3, fibroblasts indeed displayed different levels of cell 
contraction force in the resting state. Fibroblasts from MoM patients presented a nearly 
60% increase in cellular contractile force (P < 0.05) compared with fibroblasts from 
primary THA patients.  
 
Figure 6.3 Contractile forces of fibroblasts from primary THA patients and patients 
with MoM implant. (A) Bright field images of individual cell (i) and corresponding 
stress magnitude maps (ii); (B) Quantification of cellular contractile force of fibroblasts 
from the cells of individual group; n = 120 from three independent experiment; 5 
cells/patient were quantified for each experiment for MoM (8) or primary THA (8); *p 
< 0.05. 





6.3.4 Fibroblasts from each group display similar cell elastic modules 
Cell stiffness has been suggested as an indicator of cell phenotype alteration and 
multiple cellular process, for example, cell differentiation. Therefore, we further 
examined the cell elastic modules from the two groups of fibroblasts using an AFM 
technique. According to the results from the AFM study, the stiffness of fibroblasts 
from MoM patients (38.5 ± 1.9) was slightly higher than that of primary THA patients 
(33.3 ± 5.0), although the difference was not statistically different.   
 
Figure 6.4 Quantification of cell stiffness of fibroblasts from primary THA patients and 
patients with MoM implant; n = 120 from three independent experiment; 5 cells/patient 










6.3.5 Increased collagen production of fibroblasts from metal-on-metal revision 
patients 
To quantify the ability of matrix production of fibroblasts from primary and MoM 
revision patients, hydroxyproline content was measured as a surrogate to determine 
levels of collagen. A significant increase was observed in the concentration of pro-
collagen released from fibroblasts from MoM patients compared with that of patients 
with a primary THA (Figure 6.5).   
 
Figure 6.5 Increased collagen production of synovial fibroblasts from patients with 
MoM implant. Collagen released by cultured synovial fibroblasts into the cell culture 
medium after 48 hrs. Bars represent mean + SEM; n = 72 from three independent 
experiment; 3 replicates/cell were quantified for each experiment for MoM (8) or 










6.3.6 Macroscopic appearance of the synovial tissues from patients with metal-on-
metal hip implants and patients undergoing primary hip replacement  
Macroscopically, the synovial membrane collected from primary total hip replacement 
patients generally appeared to be homogenous, fatty tissue (Figure 6.6 A, B). In contrast, 
tissues from patients with MoM implants undergoing a revision operation (Figure 6.6 
C, D) appeared to be dense, pigmented and fibrotic tissues. In addition, the primary 
tissues floated in the digesting media whereas MoM revision tissue, for the majority of 
samples, sunk indicating a higher density. Tissues from patients with metal-on-metal 
hip were infiltrated with metal wear/corrosion products in some cases, which appeared 
a dark-grey or green (Figure 6.6 C, D). 
 
Figure 6.6 Macroscopic evaluation of tissue from primary and revision MoM THA. 
Synovial membrane were isolated from patients undergoing primary THA (A and B), 
patients undergoing revision MoM THA (C and D). Both tissues from primary THA 
patients appeared to be homogenous, fatty, non-fibrotic tissue. In contrast, tissue from 
revision THA patients appeared to be dense, pigmented, fibrotic tissue. Scale bar 








6.3.7 Increased collagen deposition in patients with metal-on-metal hip implants 
Picrosirius red staining for collagen and immunohistochemistry for collagen I were 
used to confirm the increase in collagen in MoM patients and to investigate its 
distribution within the tissue. The synovial membranes from primary THA patients 
were characterised by a homogenous distribution of fat cells (adipocytes) with a small 
quantity of collagen (Figure 6.7A) or collagen I (Figure 6.7D) distributed surrounding 
adipocytes or throughout the tissue. For patients with MoM implants, there was 
evidence of extensive tissue remodelling characterised by the loss of adipocytes and the 
deposition of large quantities of densely packed collagen (Figure 6.7B) and collagen I 
fibres (Figure 6.7E). There was a significant increase in the percentage positive staining 
for picrosirius red (Figure 6.7 C) and collagen 1 (Figure 6.7F) in patients undergoing 






Figure 6.7 Significant tissue remodelling in collagen deposition and increased collagen 
I expression in revision MoM THA tissue. Picrosirius red staining was used to stain 
collagen (A and B) and immunohistochemistry staining was applied to visualize 
collagen I (D and E) with quantification showed in (C) and (F). Representative images 
of synovial membrane tissues from primary THA patients (A, D) and patients with 
metal-on-metal hip implants (B, E). Bars represent mean + SEM; n = 80 from two 
independent experiment; 5 random fields/patient were imaged and quantified for each 
experiment for MoM (8) or primary THA (8); *** p < 0.001; scale bar indicates 100 







6.3.8 Increased α-smooth muscle actin expression in patients with metal-on-metal 
hip implants 
Fibroblasts are cells of distinct morphology that are responsible for the maintenance 
and deposition of extracellular matrix throughout human body. However fibroblasts, in 
particular α -SMA positive myofibroblasts, have been identified as one of the major 
effector cells in tissue repair and, in some cases, the subsequent development of 
pathologic tissue reaction in multiple tissues/organs. Therefore, synovial membrane 
from primary (Figure 6.8A) and revision MoM (Figure 6.8B) patients were stained to 
determine the the levels of myofibroblasts present. Following quantification, Figure 6.8 
C, the amount of α-SMA positive fibroblasts was significantly increased in revision 
MoM THA tissue.  
 
Figure 6.8 Increased amount of α-SMA positive fibroblasts in revision MoM THA 
tissues. Representative images of synovial membrane tissues from primary THA 
patients (A) and patients with metal-on-metal hip implants (B) with quantification 
showed in (C). Bars represent mean + SEM; n = 80 from two independent experiment; 
5 random fields/patient were imaged and quantified for each experiment for MoM (8) 





6.4 Discussion  
Despite being one of the most significant issues in the field of arthroplasty, the 
mechanism related to adverse tissue reactions to wear and corrosion debris, responsible 
for the devastating failure of MoM implants remains relatively limited. The research to 
date has largely focused on the complex inflammatory responses of immune cells 
triggered by the CoCr metal products (Papageorgiou et al., 2007, Papis et al., 2007, 
Behl et al., 2013, Smith et al., 2014), with little attention being paid to the local tissue 
homeostasis mediated by the fibroblasts. Previous work from others have shown DNA 
damage and ROS production in human fibroblasts after exposure to the CoCr micron 
sized particles (Papageorgiou et al., 2007, Behl et al., 2013). In chapter 5, the effects of 
Co2+ and Cr3+ ions on human fibroblast-matrix interaction were investigated by utilising 
a 3D collagen culture systems and found that Co2+ had a marked impact on the 
cytoskeleton, contractile forces and mechanical properties of the fibroblast without any 
detectable cytotoxic effects, inducing a profibrotic state, which were further enhanced 
by the presence of macrophages.   
In this chapter, in vitro assays were applied to characterise some of the key features of 
synovial fibroblasts to investigate their contribution to the tissue response and disease 
progression. The data demonstrated that fibroblasts isolated from patients undergoing 
a MoM revision THA were more efficient at contracting collagen gels (Figure 6.2) and 
were more responsive to stimuli such as cytokines and growth factors. They are also 
found to display altered cell force responses (Figure 6.3) compared to the control 
primary cells. Moreover, synovial tissue from patients undergoing MoM revision THA 
is macroscopically and histologically different from tissue isolated from patients 
undergoing primary THA, with evidence of extensive tissue remodelling characterised 





observed an obvious enhancement of synovial fibroblasts activation with significant 
increase in the number of myofibroblasts in the tissues (Figure 6.8). Our data highlights 
a significant enhancement of the activation of fibroblast and its important potential role 
in the undesired cellular response to wear and corrosion products.  
The response to an inflammatory lesion involves a complex interplay of diverse cellular 
and tissue elements that restrain tissue invasion and ultimately establish normal tissue 
integrity (Buckley et al., 2013). It has also become increasingly clear that the 
remodelling of the extracellular matrix has profound effects on cellular immune 
responses (Sorokin, 2010). Instead of being a passive player in the immune system, 
fibroblasts are showed to actively define the organization of tissue microenvironments 
and modulate cell activities by conditioning the local cellular and cytokine 
microenvironment (Jordana et al., 1994, Buckley et al., 2001). The inappropriate 
activation of fibroblasts prevents the resolution of acute inflammation thereby leading 
to chronic persistent inflammation (Buckley et al., 2001). 
The phenotypic changes of synovial fibroblasts are associated with dramatic functional 
alteration. How their ability to influence immune cells survival, differentiation and 
accumulation within synovium when exposed to CoCr metal and associated ions 
remains unknown. Addressing these questions in future studies will greatly improve 












Chapter 7 Discussion and future work  
7.1 Discussion 
The use of metal on metal total hip replacements has almost ceased, however implants 
containing CoCr alloys are still being widely utilized in THAs, in the modular femoral 
heads in MoP couplings as well as in dental prosthesis (Kuhta et al., 2009, Dimitriou et 
al., 2016). Significant increases in the measured metal ions released into the saliva of 
patients with dental metallic materials has been reported (Downarowicz and 
Mikulewicz, 2017). In addition, many retrieval studies have recently documented the 
adverse tissue reactions and pseudotumour formation adjacent to taper junctions in 
many total hip replacement designs (Plummer et al., 2016, Kwon et al., 2016), which 
are clinically and histologically similar to ALTRs previously reported in failed MoM 
bearings. The etiology of this soft-tissue damage has been linked to release of metal 
ions and debris from the modular taper junctions. A series of studies have examined the 
inflammatory response to CoCr ions and particulates which reveal that CoCr metallic 
debris promotes cell death and triggers the release of an array of proinflammatory 
mediators (Petit et al., 2006, Tsaousi et al., 2010, Posada et al., 2015, Kanaji et al., 2009, 
Dalal et al., 2012). However, how CoCr ions and particulates affect cell behaviour and 
modulate their activities remains largely unknown.  
When tissue damage occurs or foreign insults are detected, circulating monocytes are 
attracted to adhere to and penetrate the endothelia walls. Through a series of 
morphological and functional changes, they become macrophages in order to target 
cells and foreign bodies that need eliminating (Shi and Pamer, 2011). After 
phagocytosis, the usual fate of inflammatory macrophages is to migrate from the 





monocytes/macrophages play a critical role in the initiation and resolution of 
inflammatory response. In this thesis, using in vitro and in vivo approaches, it has been 
revealed that at moderate levels, cobalt ions and nanoparticles could prevent the efflux 
of macrophages, which would result in the accumulation of these inflammatory cells 
and subsequent prolonged inflammation. The mechanisms that underline this 
observation were clarified in chapter 4. To the best of our knowledge, this is the first 
study using an in vivo model to investigate the effects of the cobalt ions on immune 
cell’s motility. It was found that cobalt nanoparticles inhibit macrophages efflux in vivo, 
which is consistent with the results of live time cell motility monitoring and cell 
transmigration assays. This phenomenon suggests that macrophage accumulation and 
subsequent prolonged inflammation in the peri-prosthetic tissues could be partially 
explained by the fact that their migratory ability was impaired after phagocytosis of 
CoCr wear particles or exposed to ionic cobalt. As monocytes are recruited to the 
inflamed site by a gradient of chemokines and other signalling factors secreted by local 
cells, they could be trapped in the area and exacerbate the tissue damage.  A similar 
phenomenon has been previously revealed for the lipid-laden macrophages in the 
arterial intima during the development of atherosclerosis (Park et al., 2009).  
The cytoskeleton consists of protein microfilaments, intermediate filaments, and 
microtubules (Fletcher and Mullins, 2010). The cytoskeleton serves, not only as a 
framework that helps cells maintain their morphology and internal organization, but 
additionally provides mechanical support that enables cells to carry out a wide range of 
functions such as division and movement (Fletcher and Mullins, 2010). Cellular 
responses to extracellular signals frequently includes changes in cell movement and cell 
shape. Nano particles (NPs) have previously been found to have a disruptive impact on 





with NPs, which showed destabilization and degradation of actin filaments or tubulin 
structure in cells exposed to NPs (Gonzalez et al., 2015, Tay et al., 2014b, Wang et al., 
2012). Additionally NPs have been shown to influence MT network polymerization 
and further induce MT destabilization leading to straightening, thickening or shortening 
of MT structure (Tay et al., 2014a). Pernodet et al. showed that Au NPs induced 
aberrant F-actin formation and significantly decrease cell area while it was considered 
to be bioinert (Pan et al., 2009). Another study indicated that RAW 264.7 macrophages 
exposed to zinc oxide (ZnO) resulted in F-actin depolymerization and a decrease in the 
level of F-actins (Pati et al., 2016). It was speculated that the binding of Zn2+ to the 
actin network led to this perturbation as it is known that actin contain Zn2+ binding sites 
and the self-assembly of actin microfilaments could be disturbed by this binding 
(Garcia-Hevia et al., 2016). Impairments of F-actin could induce destabilization of the 
cytoskeleton and furthermore lead to permanent cell injury or even cell death (Franklin-
Tong and Gourlay, 2008). However, in this current study it was shown that, in contrast 
to the detrimental effects of some other nanoparticles on cytoskeleton networks, CoNPs 
could actively promote cytoskeleton remodelling to modify macrophages’ behaviour 
without affecting the cytoskeleton integrity or cell viability, which was triggered by the 
down-regulation of RhoA expression caused by ROS formation.     
Fibroblasts and their activated phenotype known as myofibroblasts are the most 
common cell types in connective tissue. Because of their prevalence and the critical 
role they play in determining extracellular environment, fibroblasts also serve as one of 
the most frequently used cell types for in vitro toxicity tests for biomaterials. Numerous 
studies have examined the effects of Co and Cr ions and particles on fibroblasts in 
proliferation, cytotoxicity and DNA damage in 2D culture condition (Tsaousi et al., 





fibroblasts functionality and behaviour at sub-toxic level has not been previously 
reported. Fibroblasts are the primary cell type responsible for ECM proteins synthesis 
to build up the connective tissue. Moreover, they promote ECM remodelling via 
transmitting force to contract and compact the surrounding matrices to achieve 
tensional homoeostasis, which have a significant impact on other cells’ behaviour. To 
analyse the fibroblasts’ functional and biomechanical response to both Co and Cr under 
conditions that resemble an in vivo-like environment, a 3 dimensional (3D) matrix-cell 
culture system was applied in this thesis. It was demonstrated that Co2+ promotes 
fibroblast contraction to induce ECM remodelling through its effect on fibroblast 
biomechanical properties.  Cobalt exposure was found to cause a significant increase in 
cell stiffness and enhanced contractile forces. This is in agreement with previous 
observations that the biomechanical properties of fibroblasts serve as a key regulator of 
cell’s ability to organize the ECM (Alkasalias et al., 2017). We found that Co2+ drives 
the contraction of fibroblasts by regulating MLC phosphorylation, which could be 
abrogated by ROS scavenger (Figure 5.14). CoCr particles are known to lead to the 
generation of reactive oxygen species (ROS) in a range of cell types (Samelko et al., 
2013, Behl et al., 2013, Raghunathan et al., 2013). The results indicated, for the first 
time, that this cobalt-induced ROS formation also plays a critical role in ECM 
modulation by fibroblasts.  Furthermore, it was shown in chapter 5 that cobalt exposure 
also led to differentiation of fibroblasts into myofibroblasts in the presence of 
macrophages, which could secret multiple signalling factors, such as TGFβ1 
(transforming growth factor-β1) and PDGF (platelet-derived growth factor), to enhance 
the activation of fibroblasts along with cobalt. This is consistent with the histology 
findings that the immune cells infiltrated peri-prosthetic area often showed concurrent 





More importantly, the synovial fibroblasts from patients with MoM implanted were 
successfully isolated and compared with fibroblasts from primary THA patients in this 
thesis. It was found that fibroblasts isolated from patients undergoing MoM revision 
THA were more efficient at contracting collagen matrices with altered cell traction 
forces (Figure 6.2 and 6.3). Also, MoM fibroblasts were shown to be more responsive 
to stimuli such as cytokines and growth factors compared to their normal counterparts.  
The activation of fibroblasts and subsequent alteration in ECM mechanical properties 
have many implications. For example, immune cells are able to probe and sense the 
alteration in the mechanical properties of the extracellular environment. Previous 
studies have shown that immune cells are affected by the matrix stiffness, e.g. stiffer 
substrates enhanced neutrophil transmigration (Stroka and Aranda-Espinoza, 2011) and 
release of pro-inflammatory cytokines by macrophages (Blakney et al., 2012). This in 
turn could further promote tissue reactions that result in fibrosis as showed in Figure 
6.6 or even tissue necrosis as reported in some patients. The retention of macrophages 
demonstrated in chapters 3 and 4 could further exacerbate this scenario. In addition, 
cobalt has been showed to activate macrophages to release a range of inflammatory 
mediators, which can affect ECM turnover and tissue homeostasis. For example, as a 
pleiotropic inflammatory factor, sustained IL-1β production in macrophages has been 
implicated in inducing tissue pathology and promoting the release of profibrogenic 
mediators (Daheshia and Yao, 2008, Negash et al., 2013).  TNF-α was showed to 
stimulate collagen synthesis, increased expression of TIMP-1 (tissue inhibitor of 
metalloproteinases), and decreased activity of MMP-2 (matrix metalloproteinase 2) of 
Intestinal myofibroblast (Theiss et al., 2005). It also promotes the formation of TGF via 





(Sullivan et al., 2005). Further studies are required for improved understanding of the 
interplay between fibroblasts and macrophages in the presence of cobalt.  
In conclusion, this study has identified new downstream effects of cobalt-induced ROS 
production. Cobalt was found to reduce RhoA expression in modulating macrophage 
migration and cytoskeleton organization. The effects of this signalling cascade lead to 
an enhancement in macrophage spreading, adhesion and inhibition of migration, which 
could lead to a prolonged immune cell retention thereby propagating the chronic 
inflammation. The increased podosome formation in macrophages is also associated 
with enhanced activation of MMP9 and associated increased matrix degradation. On 
the other hand, cobalt-induced production of reactive oxygen species mediated the 
alteration of the mechanical properties of fibroblast leading to aberrant tissue 
remodelling in vitro and in vivo. Moreover, the profibrotic effect could be further 
enhanced due to the retention of macrophages. The effects of cobalt on macrophages 
and fibroblast and associated mechanisms are summarized in Figure 7.1. The 
identification of these new mechanisms through which cobalt, but not chromium, ions 
and nanoparticles induce macrophage retention and ECM remodeling provides a novel 






Figure 7.1 Illustration showing the proposed mechanisms of how Co2+ and CoNPs from 
CoCr hip replacement implant affect macrophage and fibroblast functionality and lead 








7.2 Future work  
7.2.1 The use of wear debris from MoM implants  
The use of commercially available nanoparticles, while they could be chemically and 
physically different from the wear particles generated in vivo, allowed the individual 
role of the two primary elements from this alloy to be deciphered in the cellular 
response. It would be interesting to investigate wear debris from MoM implants, with 
all the challenges that this would introduce, to provide some further clinically relevant 
answers in future studies.  
7.2.2 The effects of physical properties of metal particles on cellular response  
It has been previously suggested that NPs are more bioactive than micron size particles 
(Papageorgiou et al., 2007) for the CoCr alloy.  In this thesis, it was revealed that, 
similar to Co NPs, Co2+ showed comparable effects on macrophages for both cell 
migration and cytoskeleton organization. It remains unknown if larger CoCr particles, 
of micron size, would also have such effects. In addition, there are reports that cellular 
response to metallic particles could be affected by their physical properties, such as 
surface roughness, tomography and density. Given the complexity of the physical 
properties of metal particles generated in vivo, it is of clinical relevance and importance 
to investigate how the physical properties of larger metal particles would impact 
cellular responses.  
7.2.3 The role of fibroblast activation on immune cells recruitment and accumulation 
Besides their capacity in tissue remodelling, fibroblasts are also known to play an 
important role in regulating the switch from acute resolving to chronic persistent 





and release of various cytokines, chemokines and prostanoids (Buckley et al., 2001). 
Moreover, fibroblasts also mediate the behaviour of immune cells that infiltrate the 
damaged tissue. Therefore, it is necessary to elucidate whether the activation of 
fibroblasts by cobalt is accompanied by signalling factors that regulate the activation 
and recruitment of inflammatory cells, which could ultimately lead to the identification 
of potential new therapeutic targets. 
7.2.4 The effects of CoCr on bone cells and bone homeostasis 
Many studies have revealed that cobalt and chromium have negative effects on bone 
formation and suggested that this may be associated with its detrimental effects on bone 
cells (Orhue et al., 2011, Kanaji et al., 2009). However, the molecular mechanisms that 
contributes to this dysregulated bone homeostasis has not been identified. Osteoclasts 
that derived from monocytes also play an essential role in bone homeostasis due to their 
osteolytic activity. As demonstrated in chapter 3 and 4, cobalt has significant effects on 
monocyte-derived macrophages behaviour. It would be helpful to uncover the influence 
of both Co and Cr ions and particles on the activities of osteoblasts and osteoclasts for 
preventing wear particles-related osteolysis in patients with CoCr containing implants.  
7.2.5 ARMDs in patients treated with MoM total knee arthroplasty (TKA) 
Although it is well established that MoM hip replacements leading to elevated levels of 
metal ions and ARMDs, there is little information available concerning the prevalence 
of these adverse reactions in patients with TKA implants containing CoCr alloys. It 
would be useful to analyse the extent of cobalt released from CoCr knee implant and 
investigate whether it would cause similar cellular/tissue response as reported in THA 
patients with CoCr bearing surface and the contributing factors for the possible 
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Appendix 1: Densitometric Analysis using ImageJ 
1. Convert each TIFF file, scanned from a film at a DPI of >300 to an 8-bit Image, in 
ImageJ, Figure 1. 
 
Figure 1  
2. Utilising Analyze>Gels>Gel Analyzer Options, select Label with percentages and 
Invert peaks, Figure 2. 
 
Figure 2 
3. Draw a rectangle around the first band and select Analyze>Gels>Select First Lane to 
designate lane #1. Move the rectangle to the next lane and go to Analyze>Gels>Select 








Figure 4  
4. When all the lanes have been highlighted, go to Analyze>Gels>plot lanes to bring 
up a new window displaying a histogram of each lane (Figure 5). Use the line tool to 
draw a straight line at the bottom of each peak to enclose the area under each peak 
(Figure 6). When each peak has been enclosed, utilising the magic wand from the tool 





     
Figure 5                                                         Figure 6 
5. Analyse using Analyze>Gels>Label Peaks to provide an area under each peak 
(Figure 7). 
   
Figure 7 
6. Repeat the process for each image before determining the relative density of each 






Appendix 2: A copy of publication  
 
 
 
  
 
183 
 
 
 
 
 
  
 
184 
 
 
 
 
 
  
 
185 
 
 
  
 
186 
 
  
 
187 
 
  
 
188 
 
  
 
189 
 
 
 
 
 
  
 
190 
 
 
 
  
 
191 
 
 
  
 
192 
 
  
 
193 
 
  
 
194 
 
  
 
195 
 
 
